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INTRODUCTION
Skull sutures are fibrous joints between the different bones of the skull. In adult life 
they have no function but in the foetus they allow the bones to move during the birth 
process and are involved in skull growth till the age of six years. After the age of six 
years skull growth takes place by apposition of bone at the outer site of the skull and 
resorption of bone on the inner site of the skull.
Craniosynostosis is a condition in which one or more sutures of the skull prematurely 
fuse. The term craniosynostosis was first used by Otto in 1830.1 The word “Cranio” 
refers to cranium, “Syn” to together and “ostosis” to the genesis of bone. But the first 
description of craniosynostosis dates back to Hippocrates and Galen2 and it is a dis-
order that occurs in the human species since ancient times.3 When craniosynostosis 
is caused by a mutation or deletion we speak of syndromic craniosynostosis. This is 
the case in at least 20% of the patients with craniosynostosis.4 The most prevalent 
syndromes are Apert, Crouzon, Muenke and Saethre-Chotzen. 
 In 1851 Virchow was the first to describe how skull growth is restricted in the 
plane perpendicular to the prematurely fused suture and is enhanced in the plane 
parallel to it.5 Skull growth is necessary to provide space for the growing brain, but 
in case of craniosynostosis this results in an abnormal skull shape and possibly a re-
stricted intracranial volume. In patients with syndromic craniosynostosis not only the 
neurocranium is affected but also the viscerocranium which affects the growth of the 
orbits, maxilla and mandible. This abnormal growth results in functional and morpho-
logical problems, of which the most important are raised intracranial pressure (ICP), 
ventricular dilatation, obstructive sleep apnea (OSA), Chiari I malformation, visual im-
pairments, hearing disorders, malocclusion and exophthalmus.
 The prevalence of raised ICP varies per syndrome, between 60% in Crouzon 
syndrome, 45% in Apert syndrome and 30 % in all other syndromes.6 There are many 
hypotheses for the cause of raised ICP in craniosynostosis, all of them can be related 
to the Monro-Kellie hypothesis stating that the cranium and its constituents (blood, 
cerebrospinal fluid and brain tissue) create a state of volume equilibrium. Intracranial 
pressure is stable as long as volume added is balanced by volume displaced or in 
case of children increase of the intracranial volume. In patients with craniosynostosis 
the displacement can be obstructed by limited growth of the intracranial volume, 
obstructed venous outflow caused by OSA or jugular foramen stenosis and by liquor 
resorption problems.7-9 Diagnosis of raised ICP can be difficult because it is not always 
symptomatic in patients with craniosynostosis, and papilledema can be the only clini-
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cal sign.10 Raised ICP causes papilledema because the pressure is transmitted to the 
optic nerve, causing nerve head swelling, or optic disc oedema. This can lead to loss 
of fibers of the optic nerve and permanent visual impairment. The sensitivity and 
specificity of fundoscopy for the detection of papilledema depends on experience of 
the investigator. In one study it has a high specificity (98%). Its sensitivity howeer is 
age-dependent, being 100% sensitive in children older than 8 years, with only 22% 
sensitivity in younger patients.11 
 Ventricular dilatation has a high prevalence in syndromic craniosynostosis. It 
has been reported in 30% to 70% in Crouzon and Pfeiffer syndrome and in 40% to 
90% in Apert syndrome,12 while most cases with Muenke and Saethre-Chotzen syn-
drome seem not to be affected. Enlarged ventricles can either be progressive, known 
as hydrocephalus, or non-progressive, known as ventriculomegaly. Ventriculomegaly 
may be related to primary brain development. Hydrocephalus on the other hand can 
be caused by cerebrospinal fluid outflow problems or malabsorption. Outflow prob-
lems could to be related to Chiari I malformation and to a small fossa posterior. Hy-
drocephalus can be one of the causes of raised ICP in craniosynostosis. 
 Obstructive sleep apnea is characterized by repetitive pauses in breathing 
during sleep, despite the effort to breathe. In children with craniosynostosis it is as-
sociated with midfacial hypoplasia, micrognathia, tracheamalacie, intranasal airway 
obstruction and muscular hypotonia.13 Potential complications of OSA are failure to 
thrive, behavioral problems, cor pulmonale, and sudden death.14-15 Screening for the 
presence of OSA can reliably be done with the Brouillette questionnaire16 and poly-
somnography (PSG) is generally accepted as the gold standard to diagnose and deter-
mine the severity of OSA.
 In this thesis a Chiari I malformation is considered to be present when the 
cerebral tonsils herniate 5 mm or more downward through the foramen magnum. In 
craniosynostosis a Chiari I malformation appears to be acquired, due to several fac-
tors such as; a disproportion between the cerebellum and a small posterior fossa, hy-
drocephalus and raised ICP.17 A Chiari I malformation remains symptom free in most 
patients with craniosynostosis but can cause severe problems such as; central sleep 
apnea, non-communicating hydrocephalus, muscle weakness in the head and face, 
difficulty swallowing, impaired coordination, paralysis and autonomic dysregulation. 
Diagnosis is in most cases based on MRI.
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SYNDROMES
The Apert syndrome was first described by the French Pediatrician dr. Eugène Charles 
Apert in 1906.18 The syndrome is characterized by synostosis of the coronal sutures, 
midface hypoplasia, symmetrical complex (osseous and soft-tissue) syndactyly of 
hand and feet and mental retardation. The most used classification system of the 
hand anomalies in Apert syndrome is that of Upton,19 classifying the Apert hand into 
three types according to increasing severity; type I consists of complex syndactyly 
of digits two through four with a free thumb and a simple syndactyly of the small 
finger, type II consists of complex syndactyly of digits two through five with an associ-
ated simple syndactyly of the thumb, type III consists of complex syndactyly of all the 
digits. Apert syndrome has an incidence of around 1 per 60.000 births.20-21 In 99% of 
the cases it is caused by the S252W or the P253R mutation in the FGFR2 gene.22 The 
mode of transmission is autosomal dominant, but most cases are sporadic.
 The Crouzon syndrome was first described by Octave Crouzon in 1912.23 The 
syndrome is characterized by bicoronal synostosis, but other sutures can be affected. 
In some cases the craniosynostosis develops postnataly.24 Other features that can be 
appreciated are exopthalmus, midface hypoplasia and hypertelorism. Crouzon syn-
drome is in most cases caused by mutations on the FGFR2 gene, but can also be 
caused by a distinct mutation on the FGFR3 gene. This mutation is associated with 
acanthosis nigricans.25 Crouzon syndrome has an incidence of around 1 per 25.000 
births. The mode of transmission is autosomal dominant, and it is familiar in about 
50% of the cases. 
 Pfeiffer syndrome was first described by Rudolf Arthur Pfeiffer in 1964.26 Phe-
notypically Pfeiffer is very similar to Crouzon syndrome, but is distinguished by the 
presence of broad thumbs and halluces. Genetically the syndromes can often not be 
distinguished from each other.27 Therefore we assume that both syndromes belong to 
the same broad spectrum of the same disease.
 The Muenke syndrome was first described by Glass et al. in 199428 but named 
after the one who discovered the mutation rather than the one who first described 
the phenotype. The Muenke syndrome is characterized by bilateral or unilateral syn-
ostosis of the coronal sutures, but synostosis of other sutures or the absence of cra-
niosynostosis can be seen in this syndrome. Other findings include hypertelorism, 
ptosis, midface hypoplasia, a highly arched palate, strabismus, sensorineural hearing 
loss, developmental delay, carpal bone and/or tarsal bone fusions and brachydactyly. 
The estimated birth prevalence is 1 per 30.000 births, but is probably higher because 
not all cases come to clinical attention.29-30 The Muenke syndrome is caused by the 
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P250R mutation in the FGFR3 gene.31 The mutation rate at this locus is one of the 
highest known in human genome.29 The mode of transmission is autosomal dominant 
with an incomplete penetrance and a varying expression.
 The Saethre-Chotzen syndrome was first described by dr. Haakon Saethre in 
1931 and by dr. F. Chotzen of Breslau in 1932.32-33 In Saethre-Chotzen syndrome, the 
coronal sutures can be bilateral or unilateral affected. Other features of this syndrome 
are upper eyelid ptosis, hypertelorism, strabismus, tear duct stenosis, brachydactyly, 
and cutaneous syndactyly of hand and feet. The estimated birth prevalence is around 
1 per 25.000 births. It is caused by several mutations and deletions in the TWIST1 
gene.34-35 The mode of transmission is autosomal dominant with a varying expres-
sion.36
 There are many other syndromes associated with craniosynostosis that are 
not covered in this thesis. These are the craniofrontonasal syndrome (EFNB1 gene),37 
Antley-Bixler syndrome (POR gene),38 Carpenter syndrome (RAB23 gene),39 Roberts 
syndrome (ESCO2 gene),40 Greig syndrome (GLI3 gene),41 Alagille syndrome (JAG1 
gene),42 Noonan syndrome (KRAS gene),43 Baller Gerold syndrome (RECQL4 gene),44 
Loeys-Dietz syndrome (TGFBR1 and TGFBR2 gene)45 and craniosynostosis caused by 
MSX2.46 
 If no mutation can be found and two or more sutures are closed, the term 
complex craniosynostosis is used. Patients with complex craniosynostosis are a het-
erogeneous group, which can present with a mild to a very severe phenotype. This 
group is getting increasingly smaller as more mutations are found.
CAUSES
A part of the mutations are inherited especially in cases with a mild phenotype, such 
as seen in Saethre-Chotzen and Muenke syndrome. However most cases are de novo 
mutations. The observations that the mutations have an almost exclusively paternal 
origin and that the paternal age of patients with de novo mutation tends to be 2 to 5 
years older30,47-48 have lead to the hypothesis known as the paternal age effect mu-
tations.49 Paternal age effect mutations encode for proteins with a gain-of-function 
property. Spermatogonia with these mutations are positively selected and expand 
clonally, this leads to an enrichment of sperm with mutations over time. Therefore 
unaffected fathers of a child with syndromic craniosynostosis have a slightly higher 
change of getting a second affected child, compared to diseases originated from de 
novo mutations.
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TREATMENT
In 1890 Lennelongue was the first to report on surgical treatment for craniosynosto-
sis. He used strip craniotomies to release the cranial sutures in an attempt to expand 
intracranial volume.50 This treatment was halted in 1894 after reviewing the first 33 
cases of whom 15 died.51 By the mid-1940s the strip craniotomies were again widely 
accepted. But it took till the end of the 1960s that Paul Tessier reported his tech-
niques which are now regarded as the principles of modern craniofacial surgery.
 The most commonly performed expansion for bicoronal craniosynostosis is 
the frontal orbital advancement. The general principle of this procedure is the mobi-
lization and advancement of the supraorbital bar with the forehead. This results in an 
increased volume of the anterior fossa and the orbits. 
 A posterior vault expansion is indicated in the youngest patients with Apert 
and Crouzon syndrome were a second surgery may be needed at a later age. When 
a posterior vault expansion is performed as primary surgery this leaves the face un-
touched. This makes it easier to perform a monobloc at a later age.  An exception is 
the presence of severe exorbitism or obstructive sleep apnea. In these cases a frontal 
orbital advancement together with a midface advancement or monoblock may be 
needed, to prevent vision loss or prevent the need of a tracheal cannula. During sur-
gery a large posterior bony flap is raised. It is thought that posterior vault expansion 
offers a larger volumetric increase than the frontal orbital advancement.20, 52 An alter-
native for the conventional posterior vault expansions is the spring assisted posterior 
vault expansion. The use of springs were introduced by professor Lauritzen in 1997.53 
They have since been used for various indications and forms of craniosynostosis.54-56 
The main advantage of springs is that they can be custom made per patient, are cov-
ered under the skin and need a smaller dissection.57 These properties make them less 
sensitive to mechanical failure, as is seen with internal distractors.58-59 
 The Le Fort III procedure is used for midface advancement. During this pro-
cedure the midface is mobilized along the Le Fort III fracture lines. This procedure 
is used for the treatment of midface hypoplasia and it’s related problems, such as 
obstructive sleep apnea and exorbitism and malocclusion.60 If necessary the advance-
ment of the midface can be combined with advancement of the orbits, in a single seg-
ment. This procedure was first described by Ortiz- Monasterio in 1978 and is known 
as a monobloc advancement. Another modification was proposed by van der Meulen 
in 1979, known as the bipartition.61 During this procedure the midface is divided in 
the middle with a V-shaped resection. This makes it possible to combine a monobloc 
advancement with a correction of hypertelorism.
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If hydrocephalus is the main cause of raised ICP a ventriculoperitoneal (VP) shunt 
may be indicated. This is predominantly the case in Crouzon syndrome, while in Ap-
ert syndrome most cases of enlarged ventricles remain stable over time.12 Because 
VP-shunts are associated with complications, shunt placement must be done only if 
there are no other treatment options left. Complications that are encountered are 
infection, obstruction, overdrainage and intraventricular haemorrhage.
 Besides a vault expansion patients with Apert syndrome need hand surgery 
for the complex syndactyly of the hands associated with this syndrome. To limit the 
number of procedures the first procedure is preferably done bilaterally, followed by 
two unilateral procedures. How hand surgery in Apert syndrome improves long-term 
hand function, quality of life and participation is unknown. 
THESIS AIM AND OBJECTIVES
The Dutch craniofacial center in Rotterdam is the single referral center for syndro-
mal craniosynostosis in the Netherlands and active since 1972.  Therefore we have a 
large and unique population. The aim of this thesis is to give a better perspective of 
the most prevalent syndromes associated with craniosynostosis including Crouzon, 
Muenke, Saethre-Chotzen and Apert syndrome.
The first part of this thesis presents long-term results of raised ICP, OSA, hearing and 
vision and intelligence. In chapter 2 this is done with a large retrospective study, 
where we present functional problems in patients with syndromic craniosynostosis. 
This will give a better understanding of the syndrome specific problems, which is 
needed for patient tailored treatment and follow-up. Besides the functional prob-
lems we report on the age at time of first onset of raised ICP. 
 In chapter 3 we report the long-term intellectual and visual outcome of the 
treatment protocol used in Paris and Rotterdam, were a routine vault expansion is 
performed before the age of one year if patients are referred on time. The aim of 
this protocol is to treat or prevent early episodes of raised ICP, and with that improve 
long-term intellectual and visual outcome. In the future these baseline results could 
be compared with results of other treatment protocols, e.g. the treatment protocol 
used in the craniofacial unit from London. We hope that this will improve the treat-
ment of patients with syndromic craniosynostosis.
 Furthermore, hearing loss is a much encountered problem in syndromic cra-
niosynostosis, which we think needs more attention. At this moment there are only a 
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limited number of publications on this topic with in most cases a small sample size.63-
67 Syndrome specific type, severity, and prevalence of hearing loss are presented in 
chapter 4 on which follow-up and treatment of patients should be guided. 
The second part of this thesis focuses on quality of life, and variables that influence 
quality of life. Patients with syndromic craniosynostosis have several functional prob-
lems that can negatively influence their quality of life. However there is only one 
report on quality of life in syndromic craniosynostosis.68 In chapter 5 we report the 
Health Utility Index mark 3 to give a better understanding on which and how much 
functional problems influence the quality of life. With this knowledge functional 
problems that have the largest negative influence on quality of life can get more at-
tention during treatment and follow-up. 
 Hand function is one of the functional outcomes that can have a large nega-
tively influences on quality of life in patients with Apert syndrome. There are howev-
er no reports on long-term hand function in this syndrome. In chapter 6 we report on 
hand function, and the influence of hand function on quality of life and participation 
in Apert syndrome based on several questionnaires completed by patients, parents 
or care givers. 
The last part of this thesis reports on ventricular and brain volumes and a new surgi-
cal technique; the spring assisted posterior vault expansion. 
 The growth curve of brain and ventricles in syndromic craniosynostosis could 
provide a better understanding of the development of raised ICP. Craniocerebral dis-
proportion is thought to be an important cause for the development of raised ICP. 
However cranial volume is not always too small and there are no reports on brain vol-
umes of patients with syndromic craniosynostsis.62 Therefore in chapter 7 we report 
on brain and ventricle volume in patients with syndromic and complex craniosynos-
tosis. 
 In an aim to improve the results of occipital vault expansions, springs were in-
troduced in 2009. Springs are thought to give a larger increase in intracranial volume. 
In chapter 8 we demonstrate the efficacy of spring-assisted posterior vault expansion 
by comparing this technique with the conventional method.
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ABSTRACT
Objective Little is known about the long-term prevalence of elevated intracranial 
pressure (ICP), obstructive sleep apnoea (OSA), level of education, language and mo-
tor skills,impaired sight and hearing in craniosynostosis syndromes. The objective of 
this study was to define the prevalence per syndrome of elevated ICP, OSA, impaired 
sight and impaired hearing.
Methods A retrospective study was undertaken on 167 consecutive patients diag-
nosed with Apert, Crouzon, Pfeiffer, Muenke or Saethre-Chotzen syndrome, aged 
1-25 years and treated between 1983 and 2008. The mean age at time of referral and 
review was 1 years and 2 months and 10 years and 3 months, respectively.
Results Patients with Apert and Crouzon/Pfeiffer syndromes had the highest preva-
lence of elevated ICP (33% and 53%, respectively) and OSA (31% and 27%, respec-
tively), while Saethre-Chotzen syndrome was also associated with a fair risk for el-
evated ICP (21%). The prevalence of impaired sight (61%) and hearing (56%) was 
high in all syndromes.
Conclusion Based on these data, a syndrome-specific risk profile with suggestions for 
screening and treatment is presented.
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INTRODUCTION
Syndromic craniosynostosis is a complex disease with a broad spectrum of problems. 
Elevated ICP has a high prevalence in patients with Apert and Crouzon/Pfeiffer syn-
drome1, 2 but its prevalence in Muenke en Saethre-Chotzen syndrome is unclear. One 
of the factors that is related to elevated ICP is OSA.3, 4 OSA is a known problem in chil-
dren with craniosynostosis but little is known about the prevalence among the differ-
ent syndromes.5 Other problems that are often seen are ocular and hearing deficits 
with the most frequent ocular problems being strabismus and refractive errors.6-8 
Hearing deficits are conductive in most cases caused by recurrent otitis media that 
occurs during their entire life.9, 10 A retrospective study was undertaken to determine 
the prevalence of these problems per syndrome. Based on this data, guidelines for 
follow-up of patients per syndrome are suggested.
PATIENTS AND METHODS
Study group
A retrospective study on all consecutive patients with Apert, Crouzon, Pfeiffer, Muen-
ke or Saethre-Chotzen syndrome treated at the Dutch Craniofacial Center between 
1983 and 2008 was performed. Crouzon and Pfeiffer syndrome often cannot be dis-
tinguished from each other genetically, and were therefore considered to be a ho-
mogeneous group in this study. The only exclusion criterium was an age of less than 
12 months at the time of review, leaving a total of 167 patients that were included.
Protocol for intake, treatment and follow-up
Patients who were referred to our center were assessed by a multidisciplinary team, 
which consisted of a plastic surgeon, neurosurgeon, maxillofacial surgeon, clinical 
geneticist, orthodontist, ophthalmologist, otolaryngologist, pediatrician, radiolo-
gist, psychologist and a nurse practitioner. All patients were offered a genetic analy-
sis. Depending on their phenotype exons of FGFR1, 2 and 3 and Twist were tested. 
Routine diagnostic tests besides a complete physical examination were skull X-rays, 
cephalograms, photographs, fundoscopy, and a 3D-CT scan of the skull. In case of 
anamnestic respiratory problems, a polysomnography was done either at home or 
at the clinic. The day before surgery, fundoscopy was repeated. 
Vault remodelling is scheduled at the age of 6 to 9 months or as soon as possible 
if patients were already older at time of referral. During the period under review 
a fronto-orbital advancement was performed routinely as primary vault remodel-
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ling. A monobloc was only done in the very young in case of severe OSA or severe 
exorbitism. Le Fort III or monobloc was preferably postponed until adult age, unless 
functional problems necessitated an earlier intervention. Psychosocial functioning 
and the wish for correction of patient and parents were also taking into account in 
timing the midface advancement. If for these reasons the midface advancement was 
performed between the ages of 9 and 12, the necessity for a Le Fort I 
osteotomy at 18 is the resulting consequence. Follow-up visits of these patients are 
once every 3 to 6 months during their first two-and-a-half year. Thereafter, check ups 
are once a year, up to the age of 9, after which the frequency drops to once every 3 
years until the age of 18 for those patients that have no functional problems requiring 
extra attention. During follow-up visits, patients and their parents were specifically 
asked about complaints suggestive for elevated intracranial pressure, respiratory 
problems, ocular problems and hearing difficulty. Skull circumference was measured 
and facial features were assessed. Skull X-rays were checked for impressiones, pro-
gressive sutural synostosis, sutural widening, vascular impressiones and deepening 
of the sella. Ophthalmologic and audiologic tests were regularly repeated. CT scans 
were taken on indication only, such as anamnestic complaints suggestive of increased 
ICP, decline in growth curve of skull circumference, presence of papiledema or indica-
tion for surgery (vault remodelling, Le Fort III or monobloc).
Intracranial pressure (ICP) 
Papilledema was used as an indicator of elevated ICP. A pediatric ophthalmologist 
performed all fundoscopies after pharmacological pupillary dilation with a combina-
tion of phenylephrine 2.5% and tropicamide 0.5%. Papilledema was diagnosed when 
blurring of the margins of the optic disc was present. Pseudopapilledema, which can 
resemble papilledema without being a sign of elevated ICP, was excluded. To differ-
entiate papilledema from pseudopapilledema objective refraction was performed to 
rule out high hyperopia. If papilledema was still present 1 year after surgery it was 
defined as persistent and a relapse was defined as reappearing papilledema following 
at least 1 normal fundoscopy. All patients with papilledema were considered to have 
elevated ICP. 11 ICP measurements were performed with an intraventricular catheter 
or with an intraparenchymal device (Camino or Codman). Invasive ICP measurements 
were 
recorded for at least 24 hours. Elevated ICP was defined as an average of 15 mmHg or 
higher and/or more than 3 plateau waves of 35 mmHg lasting more than 5 minutes .12 
For the analysis the term “elevated ICP” refers to the presence of papilledema and/
or elevated ICP on invasive measurement. Invasive ICP measurement was not done 
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routinely, but only in specific cases such as severe OSA, headache or persisting pap-
illedema after surgery.
Obstructive sleep apnea (OSA)
OSA was diagnosed based on a nocturnal pulse oximetry which measures the oxygen 
saturation.13 This was usually done ambulatory, with an Embletta Portable Diagnostic 
System using a Nonin Oximeter and analysed with Somnologica for Embletta soft-
ware 3.3 ENU (Medcare Flaga, Reykjavik, Iceland). From this oxygen saturation profile 
the oxygenation desaturation index (ODI) was calculated. The ODI was defined as the 
average number of oxygen desaturations of 4% or more, below the baseline level, per 
hour. Patients were classified as having mild OSA with an ODI of 1 to 5, moderate OSA 
with an ODI of 6 to 24 and severe OSA with an ODI higher than 24. 14, 15
Sight and hearing
Sight was assessed based on the test results done by an orthoptist or ophthalmolo-
gist. Sight was scored as normal, myopic, hyperopic, astigmatic, anisometropic or 
blind. Hearing was assessed based on the results of hearing tests peformed by an 
otolaryngologist or audiologist. Hearing was scored as normal or loss due to conduc-
tive, sensorineural or mixed cause.
Statistical methods
Statistical analyses were performed using SPSS 14.0 for Windows 2000. All numbers 
are expressed as average and range. The Pearson Chi-square was used or when a 
table contained numbers smaller than 5 the Fisher’s exact test was used to compare 
proportions. A 2-sided p-value of 0.05 or less was considered significant.
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RESULTS
Baseline
Of the 167patients who were included, 36 had Apert, 55 had Crouzon/Pfeiffer, 38 
had Muenke and 38 had Saethre-Chotzen syndrome. The mean age at time of refer-
ral and review was 1 years and 2 months and 10 years and 3 months respectively. 
Of the 167 patients 81 (48%) were boys and 123 (74%) diagnoses were confirmed 
genetically (table 1). Of the 43 in whom no mutation was found 12 were not tested, 
because parents did not give consent or they were tested in another hospital but no 
information was available. In the Apert patients 24 were tested, 16 had the S252W 
mutation and 8 the P253R mutation. In 9 of the tested patients with Crouzon/Pfeiffer 
no mutation was found. No TWIST mutation or deletion was found in eleven patients 
with Saethre-Chotzen, in whom a FGFR2 or 3 mutation was excluded. In these pa-
tients we sticked to the clinical diagnoses made by the geneticist. All patients with 
the Muenke syndrome had the FGFR3 P250R mutation. Type of primary surgery is 
described in table 2. No surgery was performed in 10 patients because they were 
relatively old at time of referral and didn’t have signs of elevated ICP or because 
their parents did not give their consent. The mean age at primary vault expansion 
was 14 months (2 months -9 years). A total of 92 (55%) patients underwent surgery 
before the age of 1 year. The main reason for performing primary skull remodellation 
after the age of 1 year was a delay in referral. In 14 of the 167 (8%) a second vault 
expansion was needed and in one a third vault expansion was needed. The indication 
for this secondary surgery was elevated ICP in 8, scheduled fronto-orbital surgery 
after initial occipital expansion without any sign of elevated ICP in one and in five 
patients because of unsatisfactory aesthetic effect of the first vault expansion. Of the 
14 patients with a second vault expansion result, three patients were referred for a 
second opinion following initial vault surgery that was performed by a surgeon who 
was inexperienced with the treatment of syndromic craniosynostosis. In 29 patients 
(12 Apert and 17 Crouzon/Pfeiffer syndrome) 37 midface advancements were con-
ducted. Complications caused by midface advancement were previous described by 
Nout et. al. 16 Type and timing of the midface advancements are described in table 3. 
A ventricular peritoneal shunt was placed in 13 patients (3 Apert, 9 Crouzon/Pfeiffer, 
and 1 Muenke syndrome) because progressive ventricular dilatation was present and 
intracranial volume was more than appropriate.
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Table 1 overview of genetic diagnosis
Apert
N=36 
Crouzon/
Pfeiffer   
N = 55 
Muenke
N=38
Saethre-
Chotzen
N=38
FGFR2
S 252 W 16
P 253 R 8
C 342 Y 4
C 342 W 1
C 342 T 1
C 278 F 4
Y 105 C 1
Y 340 H 3
F 276 V 2
G 271 V 1
G 338 R 1
Q 289 P 3
S 351 C 1
S 354 C 1
S 267 P 3
W 290 R 3
A 362 T 3
C 342 R 2
C 342 W 1
S 351 C 1
K 641 R 1
1084+3a>g 1
FGFR 3
A 391 E 1
P 250 R 38
TWIST
Y103X 2
D157A 1
N114S 1
R116G 1
P136S 1
P136H 1
R749C 1
T137M 1
7p21 1
165ins10 2
417dup21 1
CA-repeat 1
unilateral deletion 
TWIST region chr. 7
3
Deletion region 7p21 3
No mutation found 9 11
Not tested 12 7 7
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Intracranial pressure
A complete fundoscopic assessment was performed in 164 patients, of them 55 (33%) 
were diagnosed with elevated ICP on at least one occasion. The mean age at the first 
diagnosis of elevated ICP was 3.5 years (5 months-18.3 years). Forty-two were diag-
nosed based on the presence of papilledema and 13 based on the presence of papill-
edema and a positive invasive ICP measurement. Invasive measurements were made 
when papilledema was present without any clinical or radiological evidence for el-
evated ICP. The prevalence of papilledema varied strongly before and after first vault 
expansion and among different syndromes (table 4). The 1-year cumulative incidence 
(CI) of first occurrence of papilledema varied strongly between different syndromes 
and in time (figure 1).
 
Figure 1 1-year cumulative incidence of first occurrence of papilloedema per syn-
drome. Includes only patients checked for papilloedema at least once every 3 years, 
Apert syndrome n= 32, Crouzon/Pfeiffer syndrome n=47, Muenke syndrome
n=36 and Saethre-Chotzen syndrome n=36
Table 2 Overview of primary vault expansion per syndrome
Syndrome Primary 
expansion
Secondary 
expansion
Midface 
advancement
Apert 35 (95%) 5 (14%) 16 (43%)
Crouzon/Pfeiffer  46 (81%) 10 (22%) 21 (37%)
Muenke 39 (100%) 2 (5%) 0
Saethre-Chotzen 34 (89%) 5 (15%) 0
 Total 154 22 (14%) 37
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Table 4 Prevalence of papilloedema before and after the first vault expansion
preoperativea postoperativeb total
Apert syndrome 2/22 (9%) 11/31 (35%) 12/36 (33%)
Crouzon/Pfeiffer syndrome
Muenke syndrome
Saethre-Chotzen syndrome
a Number of patients with papilloedema divided by the number of patients 
tested for papilloedema
b Includes new onset and recurrent cases of papilloedema
Obstructive sleep apnea
Because of a high suspicion for respiratory problems (e.g., snoring, difficulty in 
breathing during sleep or apnoeas during sleep) in 66 patients, a screening for OSA 
with nocturnal pulse oximetry was done. In 30 (18%) of the 167 patients, OSA was 
diagnosed. Patients with Apert and Crouzon/Pfeiffer syndromes had a much higher 
prevalence of OSA than patients with Muenke and Saethre-Chotzen syndromes, and 
if OSA was present in patients with Muenke and Saethre-Chotzen syndromes it was 
only mild (Table 5).
Sight
In 132 patients information of sight was available. Refractive errors were reported in 
69 (52%) patients, 18 were myopic and 51 hyperopic (Table 6). In 48 (70%) patients it 
was corrected with glasses. Astigmatism was reported in five (4%), anisometropia in 
five (4%) and severe visual loss in four (3%). The four patients with severe visual loss 
were previously reported by Bartels et al.17 Strabismus was diagnosed in 81 patients. 
Patients with Apert syndrome had significantly (P < 0.001) more strabismus than all 
patients with other syndromes (Table 6).
Table 3 Type and timing of first midface advancement
Average age of first 
midface advancement
(years)
Apert
(n=12)
Crouzon/Pfeifer 
(n=17)
Monoblock 2.3 5 6
Le fort III 10.3 6 9
Le fort II 10.3 1 2
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earing
Hearing loss was reported in 65 of 119 (55%) patients. Conductive hearing loss was 
reported in 62 (45%), sensorineural hearing loss (SNHL) in six (4%) and mixed hearing 
loss was reported in 10 (7%) of the patients. The prevalence was the highest in Apert 
and Muenke syndromes (Table 6). Of the 16 patients with SNHL, four had Apert syn-
drome, five had Crouzon/Pfeiffer syndrome and seven had Muenke syndrome. Con-
ductive hearing loss was present in 20 patients with Apert syndrome, in 19 patients 
with Crouzon/Pfeiffer syndrome, in 20 patients with Muenke and in 13 patients with 
Saethre-Chotzen syndrome. Eighteen of the 140 (13%) patients needed a hearing aid: 
four patients with Apert syndrome, nine with Crouzon/Pfeiffer syndrome, three with 
Muenke syndrome and two with Saethre-Chotzen syndrome.
DISCUSSION
This study highlights the high prevalence of elevated ICP in patients with Apert, Crou-
zon/Pfeiffer and Saethre-Chotzen syndromes. OSA is prevalent in patients with Apert 
and Crouzon/Pfeiffer syndromes and hearing and visual problems are frequent in all 
of the syndromes. This retrospective description of our population guides us to a di-
agnosisspecific screening and treatment protocol (Table 7). 
 All patients need genetic analysis to establish the diagnosis, for selective 
Table 5 Number of patients with OSA per syndrome
Mild Moderate Severe Total
Apert 4 (11%) 3 (8%) 4 (11%) 11/36 (31%)
Crouzon/Pfeiffer 8 (15%) 4 (7%) 3 (5%) 15/55 (27%)
Muenke 2 (5%) 0 0 2/38 (5%)
Saethre-Chotzen 2 (5%) 0 0 2/38 (5%)
Table 6 Prevalence of refractive errors, strabismus and impaired hearing
Refractive error Strabismus Impaired hearing
Apert 22/29 (76%) 27/29 (93%)a 21/29 (72%)
Crouzon/Pfeiffer 16/41 (39%) 27/43 (63%) 20/40 (50%)
Muenke 17/35 (49%) 14/36 (39%) 24/36 (67%)
Saethre-Chotzen 14/27 (52%) 13/35 (37%) 13/35 (37%)
a Statistical significant compared to all other syndromes.
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screening on related abnormalities, genetic counselling and research. Given the fact 
that we never encountered a mutation in the FGFR1 gene, we have now stopped rou-
tine analysis of this gene Table 1. 
 In general, all patients undergo vault expansion within their first year of 
life,18,19 but surgery is scheduled earlier whenever papilledema is detected. Accord-
ing to our current protocol, initial vault expansion in patients with Apert or Crouzon/
Pfeiffer syndrome is occipital remodelling. This way we leave the fronto-orbital area 
untouched, which facilitates a monobloc at a later stage. In Muenke and Saethre-
Chotzen syndromes, we choose to perform a fronto-orbital advancement to expand 
the cranial volume and restore the appearance of their upper face. Given the very 
low risk on elevated ICP in Muenke syndrome and reports on disappointing aesthetic 
results requiring additional surgery,20-22 we suggest to postponement of surgery for 
these patients (Table 7). 
 A monobloc with distraction is chosen as primary surgery whenever patients 
suffer from severe OSA and/or severe exophthalmus. Some patients with Crouzon/
Pfeiffer syndrome may not develop craniosynostosis at all or postnatal. These patients 
should be seen at an interval of 3 months within the first 2 years and vault surgery 
is indicated whenever increased ICP is detected. Despite early vault expansion, the 
prevalence of postoperative new-onset elevated ICP remained high in our and other 
studies especially for patients with the Apert, Crouzon/Pfeiffer and Saethre-Chotzen 
syndromes.18,23 The craniofacial group from London has presented similar findings in 
patients with Apert syndrome,2 in whom vault expansion was only performed once 
signs of elevated ICP were detected. Despite surgery at a later age, these patients 
experienced a similar risk on re-occurrence of increased ICP at about 5 years of age. 
Apparently, expansion of the skull does prevent and treat increased ICP for a few 
years. The second episode with elevated ICP about the age of 4-5 years is not related 
to a craniocerebral disproportion because most of the brain growth has already taken 
place. Other possible factors that can cause the second rise in ICP are OSA,4 hydro-
cephalus and venous hypertension. 
 To diagnose elevated ICP, we recommend yearly fundoscopy in Apert, Crou-
zon/Pfeiffer and SaethreeChotzen syndromes up to the age of 6 and for Muenke up 
to the age of 2. If papilloedema is present, a computed tomography (CT) or magnetic 
resonance imaging (MRI) is indicated to exclude progressive ventricular dilatation. 
In this study, we probably have an underestimation of the prevalence of OSA due to 
measuring only a selected group of patients with anamnestic breathing difficulties 
and due to the use of pulse oximetry instead of polysomnography. Pulse oximetry is a 
diagnostic test for straightforward OSA but a negative pulse oximetry cannot rule out 
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OSA.13 Taking into account these limitations, we found OSA in more than 25% of the 
suspected children with Apert and Crouzon/Pfeiffer syndromes and in 5% of the chil-
dren with Saethre-Chotzen and Muenke syndromes. Because of the high prevalence 
of OSA in Apert and Crouzon/Pfeiffer syndromes, we advocate yearly screening for 
OSA with polysomnography. Children with Saethre-Chotzen or Muenke syndromes 
should be tested when difficulties with breathing during sleep are reported. Once the 
presence of OSA is confirmed, additional work-up is indicated including inspection of 
the size of the tonsils and endoscopy of the upper airways to determine the level(s) of 
obstruction. In a previous study we have demonstrated that OSA in syndromic cranio-
synostosis can be caused by airway obstruction at various levels and is therefore not 
always cured by a mid-face advancement (Bannink 2009 submitted). Treatment of 
OSA should be individualised for each specific patient, depending on severity of OSA, 
level of obstruction, contributing factors to OSA, age of the patient and additional 
functional or psychosocial problems. Treatment may consist of adjusting the sleeping 
position, nasal spray with steroids, respiratory support, for instance, with nocturnal 
oxygen, Continuous positive airway pressure (CPAP) or tracheal cannula, (adeno) ton-
sillectomy, maxillary or even mandibulary advancement or a monobloc procedure. 
 This retrospective study showed that impaired sight and hearing had a high 
prevalence in all syndromes and should therefore be an integral part of follow-up. 
Regular screening is therefore indicated. Genetic analysis is necessary for counselling 
and screening on syndrome-specific anomalies and functional deficits. Follow-up by 
a multidisciplinary team is needed till the age of 18 years to guarantee the best pos-
sible outcome. 
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Table 7 O
verview
 of diagnosis-specific screening and treatm
ent protocol
Clinical diagnosis
Apert
Crouzon/Pfeiff
er
M
uenke
Saethre-Chotzen
Com
m
ents
G
enetic research
FG
FR
2
FG
FR
2
1st. P250R
 FG
FR
3
2nd TW
IST
1st TW
IST
2nd P250R
 FG
FR
3
N
o F
G
F
R
1 analysis in-
cluded
F
undoscopy
Y
early up till 6 years
Y
early up till 6 years 
In patients w
ithout
craniosynostosis 
every 3
m
onths during the 
fi
rst tw
o
years
A
t age of 2 years
Y
early up till 6 years
A
t fi
rst visit and pre-sur-
gery in all patients.
Papilloedem
a w
ithout 
clinical or radiological 
sym
ptom
s: invasive IC
P 
m
easurem
ent
P
olysom
nography 
and/or pulse-
oxim
etry
Y
early till 6 years. F
or older patient only if 
anam
nestic
breathing diffi
culties are present. Y
early 
after surgical
treatm
ent of m
oderate or severe O
SA
If anam
nestic breathing
diffi
culties are present
If O
S
A
 is diagnosed: 
inspection of tonsils and 
endoscopy of upper airw
ay
H
earing
O
toscopy and tym
panom
etry at all ages O
toacoustic E
m
ission (O
A
E
) till 4 years P
ure tone audiom
etry in patients of 4 
years and older If a hearing defi
cit is found on O
A
E
 or pure tone audiom
etry, B
rainstem
 R
esponse A
udiom
etry is indi-
cated.
Sight
A
t fi
rst visit: screening for strabism
us, if present; further ophthalm
ic w
ork up is needed. W
hen possible given child’s 
developm
ent, inform
ation about visual acuity is required.
(3D
-)C
T scan
P
rior to any craniofacial surgery in all patients
M
R
I
A
t age 0 and 4
A
t age 0 and 4
-
-
If papilloedem
a is
present
First cranial vault
rem
odelling
O
ccipital expansion betw
een 6 and 9 
m
onths (if synostosis is present) If S
evere 
O
SA
 or severe
exorbitism
 present: m
onobloc +
 distraction
Fronto-orbital advancem
ent betw
een 6 and 
9 m
onths
R
aised IC
P in 
follow
-up
occipital expansion w
ith distraction or 
biparietal
w
idening based on shape of skull
occipital rem
odelling
M
idface advance-
m
ent
(m
onobloc or Le 
Fort III w
ith 
istraction)
R
elative indication:
B
etw
een age 9 to 12 (and
Le Fort I at 18) or at 18
N
ot indicated
P
sychological testing
A
t the age of 1.5; 3.5; 6; 8; 12; 15 and 18 years
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ABSTRACT
Background The current literature provides no data on long-term intellectual out-
come of patients with syndromic craniosynostosis. This information is needed to 
evaluate treatment protocols and find predictors for intellectual functioning at an 
adult age.
Objective To report on the long-term intellectual and visual outcome in patients 
with syndromic craniosynostosis of two major craniofacial units.
Methods A total of 147 patients were included: 95 from Paris and 52 from Rot-
terdam. Patients with Crouzon, Saethre-Chotzen and Apert syndrome who had 
received a vault expansion were included if they had an IQ test at the age of 6 years 
or older. Both units routinely perform vault expansions between the age of 6-9 
months. Data of visual acuity are reported for a subgroup of 39 patients from the 
Rotterdam cohort.
Results There was a good long-term intellectual outcome in patients with Crouzon 
and Saethre-Chotzen. Patients with Apert syndrome had a significantly lower IQ 
compared to both other syndromes (p<0.001). However, in all three syndromes a 
significantly larger proportion had an IQ lower than -2 sd compared to the normal 
population (46% Apert, 16% Crouzon, 12% Saethre-Chotzen, 2.3% norm). On aver-
age, a good vision was found in all syndromes. Nevertheless, the visual acuity of the 
best corrected eye was ≤ 0.5 in 8% of the patients.
Conclusion With our current policy to perform early vault expansions a good long-
term intelligence and visual acuity could be achieved. However, despite early vault 
expansion a number of cases will still have a low IQ.
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INTRODUCTION
The most common syndromes associated with craniosynostosis are Crouzon, Sa-
ethre-Chotzen, Apert and Pfeiffer syndrome.1-2 Intelligence levels in patients with 
syndromic craniosynostosis can be within normal limits, but also severely compro-
mised. The current literature provides no data on long-term intellectual
outcome. This information is needed to evaluate treatment protocols and find pre-
dictors for intellectual functioning at an adult age. Some studies with a short follow-
up report on variables that may relate to intelligence and development; syndrome 
diagnosis probably has the largest influence. Another potential variable is age at 
time of first vault expansion. In addition, family environment, parental education,
associated hydrocephalus and brain malformations might also be related to intel-
ligence.3-8 A vault expansion is needed to correct functional and morphologic prob-
lems due to growth restriction caused by craniosynostosis. In the most severe cases 
several surgical procedures are required over time. The main indication for vault 
expansion is raised intracranial pressure (ICP).2, 9  If left untreated, raised ICP may 
lead to visual impairment and may have a negative influence on neurocognitive
development.2, 10-11 Therefore, IQ and visual acuity are two important long-term 
outcome parameters for the assessment of treatment protocols in syndromic cra-
niosynostosis.  The treatment protocol of both the participating units consists of a 
routine vault expansion between the ages of 6-9 months, if patients are referred on 
time. Screening for raised ICP is done at first presentation of the patient. If papill-
edema is present, the vault expansion will be planned before the age of 6 months. 
Patients with Apert, Crouzon and Pfeiffer syndrome will receive a posterior vault ex-
pansion as initial surgery in most instances. This to preserve the facial profile in case 
of midface hypoplasia, and to leave the frontal part of the skeleton untouched for 
a monobloc or facial bipartition at a later age. A monobloc is only done as primary 
surgery in cases with severe OSA and/or exorbitism. Patients with Saethre-Chotzen 
syndrome will receive a frontal-orbital advancement as they never need a midface
advancement. After the vault expansion, annual screening for raised ICP will be 
done until age 6 years. After this age screening continues regularly until age 18 
years. The current treatment protocol is based on previous studies, with short-term 
results on mental outcome.2, 4 The aim of this study is to report on longterm intel-
lectual and visual outcome of two craniofacial units who perform vault expansions 
before the age of 1 year.
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METHODS
Patients with Apert, Crouzon, Pfeiffer, and Saethre-Chotzen syndrome were included 
from prospective cohorts in Hôpital Necker Enfants Malades (Paris, France) and the 
Sophia Children’s Hospital (Rotterdam, the Netherlands). Patients were included if 
they received a vault expansion and had an IQ test at the age of 6 years or older.
In both units intelligence was tested with the Wechsler Intelligence Scale for Chil-
dren (WISC),12 by a pediatric psychologist. In the normal population, the WISC has 
an average value of 100 and a standard deviation (sd) of 15. Patients with an IQ ≤ 50 
cannot be reliably tested with the WISC and were considered to have an IQ too low 
to test. We defined an IQ of 85 or higher as normal based on the 10th edition of the 
World Health Organization International Classification of Diseases. Syndrome diag-
nosis was based on genetic testing and/or a clinical diagnosis. Because Crouzon and 
Pfeiffer syndrome often cannot be distinguished from each other, even from a ge-
netic point of view,13 they were considered to be a homogenous group. All patients 
were seen by a pediatric ophthalmologist to screen for the presence of raised ICP 
and to test visual acuity. The diagnosis of raised ICP was based on the presence of 
papilledema seen with fundoscopy. Visual acuity was tested with the help of a Snel-
len chart, and the best corrected visual acuity at the last visit was used for analysis. 
All charts of the Rotterdam patients were reviewed. 
 Predictors of intelligence were tested with the help of an ordinal regression 
model. The IQ data were divided into four strata to prevent the exclusion of patients 
who were not able to complete the test due to low intelligence; those patients 
would automatically fall into the first stratum. Predictors of visual acuity were tested 
with the help of a linear regression model. All analyses were done with SPSS 16.0 
for Windows. Differences were considered statistically significant with a 2-sided p-
value of 0.05 or less.
RESULTS
A total of 147 patients were included (95 from Paris and 52 from Rotterdam), their 
characteristics are presented in Table 1. Intelligence was too low to test in 10 (7%) 
patients; these included 4 (11%) patients with Apert syndrome, 4 (6%) with Crouzon 
syndrome, and 2 (4%) with Saethre-Chotzen syndrome. After excluding these 10 pa-
tients, the average IQ was 75 in Apert syndrome, 98 in Crouzon and 102 in Saethre-
Chotzen syndrome. There was no difference in mean IQ between both centers. 
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Vault expansions were performed between age 0.13 and 3.85 (median 0.78) years. 
In the entire group, there was no relation between age at time of surgery and IQ 
(p=0.188). Table 2 presents the percentage of patients with a normal IQ (≥85), 
stratified by age at time of vault expansion. Table 3 presents the distribution of the 
IQ per syndrome stratified by early (before age 1 year) and late surgery. Patients 
with Apert syndrome had a significantly lower IQ (p<0.001). Gender had no influ-
ence on IQ (p=0.319).
 Visual acuity was tested in 39 patients with an average age of 9.4 years at 
the latest test (this could not be tested in 11 patients due to low intelligence and 
was missing in 4). These 39 patients included 7 patients with Apert, 19 with Crou-
zon, and 13 with Saethre-Chotzen syndrome. The average visual acuity was 0.80 in 
Apert syndrome, 0.82 in Crouzon syndrome, and 0.93 in Saethre-Chotzen syndrome. 
Visual acuity was ≤0.5 in 3 (8%) patients, all with Crouzon syndrome. Low visual acu-
ity was due to myopia gravior in 1 patient; the other two patients had severe pap-
illedema earlier in life, leading to optic disc atrophy and therefore low visual acuity 
(0.3 and no light perception, respectively).
Table 1 Patient characteristics
Paris Rotterdam Total
Patients 95 52 147
Gender M/F  49/46 27/25 76/71
Apert 26 11 37
Crouzon/Pfeiffer 42 20 62
Saethre-Chotzen 27 21 48
Median age at vault 
expansion, in years 
(range)
0.6 (0.1 - 3.9) 1.0 (0.2 - 3.5) 0.78 (0.1 - 3.9)
median age at IQ test, 
in years (range)
11.4 (6.0 - 18.7) 9.1 (6.2 - 13.3) 10.7 (6.0 - 18.7)
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Table 2 Patients with a normal IQ (≥ 85) stratified by age at time of surgery
0 - 6 months at 
surgery
6 - 12 months at 
surgery
12 months - 4 
years at surgery
Apert 7/16 (44%) 7/17 (41%) 1/4 (25%)
Crouzon/Pfeiffer 7/12 (58%) 9/11 (82%) 30/39 (77%)
Saethre-Chotzen 12/14 (86%) 14/20 (70%) 11/14 (79%)
Table 3 Distribution of IQ per syndrome
IQ<-3sd
(<55)
-3sd< IQ 
<-2sd
(55-70)
2sd< IQ 
<-1sd
(70-85)
-1sd< IQ 
<0sd
(85-100)
0sd< IQ 
<+1sd
(100-115)
+1sd <IQ
(>115)
Apert 24% 22% 14% 37% 3% 0%
Crouzon/Pfeiffer 11% 5% 10% 42% 16% 16%
Saethre-Chotzen 8% 4% 13% 25% 29% 21%
Normal 
population
0.1% 2.2% 13.6% 34.1% 34.1% 15.9%
sd = standard deviation
DISCUSSION
The current study is not a comparative study for early versus late surgery but a long-
term follow-up analysis of IQ and visual acuity after a protocol with the intention to 
treat early. We found that long-term intelligence is within the normal limits in most 
patients with Crouzon and Saethre-Chotzen, and in some patients with Apert syn-
drome. However, despite early surgical intervention some patients will end up with
a low IQ. In the normal population, 2.3% of the patients have an IQ of ≤ -2 sd (≤70). 
We found an IQ of ≤ -2 sd in 16% of the patients with Crouzon, 12% with Saethre-
Chotzen and in 46% with Apert syndrome. People with an IQ of ≤ -2 sd are unable to 
live and work independently. Therefore, parents should be told that there is a risk 
that their child’s intelligence might be low even when the child has a mild pheno-
type, as can been seen in Crouzon and Saethre-Chotzen syndromes. 
 On average good visual acuity was observed in all syndromes. However, 
visual impairment (defined as a visual acuity ≤0.5 in the best corrected eye) was 
found in 8% of the patients, all with Crouzon syndrome. This is a smaller propor-
tion compared to the literature where visual impairment is reported in 17%-35% 
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of the patients with these syndromes.14-17 Thus, early management of children with 
syndromic craniosynostosis might improve the ophthalmological outcome. The 
main reasons for suboptimal visual acuity are ametropia and amblyopia. Risk fac-
tors for amblyopia seen in syndromic craniosynostosis include strabismus, ametro-
pia, astigmatism and ptosis.16-17 Optic nerve atrophy is reported in 5%-16% of the 
patients with Apert and Crouzon syndrome15, 17-18 and in about 10% of the patients 
with Saethre-Chotzen syndrome.19-20 However, this finding was not observed in our 
children with Saethre-Chotzen syndrome. In our series, two patients (5%) had a low 
visual acuity due to previous papilledema leading to optic atrophy before they were 
referred to our unit, and one patient (3%) had low visual acuity caused by myopia 
gravior. 
 We found no relation between age at time of surgery and long-term IQ. This 
could be related to the fact that biases which influence age of surgery probably also 
influence IQ. In fact, patients with a more severe phenotype are generally diagnosed 
early and receive surgery before the age of 1 year, while patients with a mild phe-
notype have a higher chance to be referred late and have surgery after the age of 
1 year. The question whether age at time of vault expansions influences long-term 
intelligence in syndromic craniosynostosis cannot be answered without a random-
ized clinical trial, or at least comparison with data from a center with a protocol to 
operate late. To our knowledge there are reports from three different centers on 
the timing of surgery and early intellectual outcome in syndromic craniosynostosis. 
Of these, two did not find a relation,3, 6-7 while the center in Paris did find such a 
relation, including nonsyndromic brachycephaly.2, 4-5, 21 However, most patients with 
unisutural non-syndromic craniosynostosis have a satisfactory mental development 
irrespective of the age at time of surgery.22-23 The main predictive factor of long-
term mental outcome in non-syndromic and syndromic craniosynostosis appears to 
be the initial level of development.2, 23-24 
 One study has described another treatment protocol, where a vault expan-
sion in Apert patients is performed only when signs of raised ICP are present.25 A 
total of 90% of the patients treated with this protocol needed a surgical intervention 
for raised ICP, of which 67% received a vault expansion at a mean age of 2.2 years. 
In patients with Crouzon syndrome the prevalence of raised ICP is even higher, and 
probably all patients will need a surgical intervention.2, 9 Therefore, this latter proto-
col probably prevents surgery in only a very small group. At the ages of 3-4 years a 
similar increase of raised ICP is detected for both treatment protocols.9, 25 Further-
more, there are no reports on long-term intellectual and visual outcome of such a 
protocol; additional studies are needed to determine its safety.
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Conclusion
With the policy to perform vault expansions before the age of 1 year and with a 
strict follow-up, a good long-term IQ and visual acuity can be achieved. However, 
despite early vault expansion a limited number of cases will still have only low neu-
rocognitive development.
REFERENCES
1.  Johnson D, Wilkie AO. Craniosynostosis. Eur J Hum Genet. Apr 2011;19(4):369-376.
2.  Renier D, Lajeunie E, Arnaud E, Marchac D. Management of craniosynostoses. Childs Nerv  
 Syst. Nov 2000;16(10-11):645-658.
3.  Patton MA, Goodship J, Hayward R, Lansdown R. Intellectual development in Apert’s 
 syndrome: a long term follow up of 29 patients. J Med Genet. Mar 1988;25(3):164-167.
4.  Renier D, Arnaud E, Cinalli G, Sebag G, Zerah M, Marchac D. Prognosis for mental function in
 Apert’s syndrome. J Neurosurg. Jul 1996;85(1):66-72.
5.  Renier D, Cinalli G, Lajeunie E, Arnaud E, Marchac D. [Oxycephaly, a severe craniosynostosis.
 Apropos of a series of 129 cases]. Arch Pediatr. Aug 1997;4(8):722-729.
6.  Yacubian-Fernandes A, Ducati LG, Silva MV, et al. [Crouzon syndrome: factors related to the
 neuropsychological development and to the quality of life]. Arq Neuropsiquiatr. Jun
2 007;65(2B):467-471.
7.  Yacubian-Fernandes A, Palhares A, Giglio A, et al. Apert syndrome: factors involved in the
 cognitive development. Arq Neuropsiquiatr. Dec 2005;63(4):963-968.
8.  Kapp-Simon KA, Leroux B, Cunningham M, Speltz ML. Multisite study of infants with single
 suture craniosynostosis: preliminary report of presurgery development. Cleft Palate 
 Craniofac J. Jul 2005;42(4):377-384.
9.  de Jong T, Bannink N, Bredero-Boelhouwer HH, et al. Long-term functional outcome in 167
 patients with syndromic craniosynostosis; defining a syndrome-specific risk profile. J Plast  
 Reconstr Aesthet Surg. Oct 2010;63(10):1635-1641.
10.  Bartels MC, Vaandrager JM, de Jong TH, Simonsz HJ. Visual loss in syndromic 
 craniosynostosis with papilledema but without other symptoms of intracranial 
 hypertension. J Craniofac Surg. Nov 2004;15(6):1019-1022; discussion 1023-1014.
11.  Renier D, Sainte-Rose C, Marchac D, Hirsch JF. Intracranial pressure in craniostenosis. J 
 Neurosurg. Sep 1982;57(3):370-377.
12.  Wechsler D. Wechsler Intelligence Scale for Children, 3rd edition (WISC-III). San Antonio, TX:
 The Psychological Corporation. 1991.
13.  Rutland P, Pulleyn LJ, Reardon W, et al. Identical mutations in the FGFR2 gene cause both
 Pfeiffer and Crouzon syndrome phenotypes. Nature genetics. Feb 1995;9(2):173-176.
14.  Khan SH, Nischal KK, Dean F, Hayward RD, Walker J. Visual outcomes and amblyogenic risk
 factors in craniosynostotic syndromes: a review of 141 cases. Br J Ophthalmol. Aug
 2003;87(8):999-1003.
15.  Khong JJ, Anderson P, Gray TL, Hammerton M, Selva D, David D. Ophthalmic findings in
 Apert’s syndrome after craniofacial surgery: twenty-nine years’ experience. Ophthalmology.  
 Feb 2006;113(2):347-352.
51
Long-term outcome
16.  Hertle RW, Quinn GE, Minguini N, Katowitz JA. Visual loss in patients with craniofacial
 synostosis. Journal of pediatric ophthalmology and strabismus. Nov-Dec 1991;28(6):344-  
 349.
17.  Tay T, Martin F, Rowe N, et al. Prevalence and causes of visual impairment in 
 craniosynostotic syndromes. Clinical & experimental ophthalmology. Jul 2006;34(5):434-  
 440.
18.  Gray TL, Casey T, Selva D, Anderson PJ, David DJ. Ophthalmic sequelae of Crouzon syndrome.
 Ophthalmology. Jun 2005;112(6):1129-1134.
19.  Kress W, Schropp C, Lieb G, et al. Saethre-Chotzen syndrome caused by TWIST 1 gene
 mutations: functional differentiation from Muenke coronal synostosis syndrome. Eur J Hum
 Genet. Jan 2006;14(1):39-48.
20.  Jadico SK, Huebner A, McDonald-McGinn DM, Zackai EH, Young TL. Ocular phenotype
 correlations in patients with TWIST versus FGFR3 genetic mutations. J AAPOS. Oct
 2006;10(5):435-444.
21.  Arnaud E, Meneses P, Lajeunie E, Thorne JA, Marchac D, Renier D. Postoperative mental and
 morphological outcome for nonsyndromic brachycephaly. Plast Reconstr Surg. Jul   
 2002;110(1):6-12
22.  Mathijssen I, Arnaud E, Lajeunie E, Marchac D, Renier D. Postoperative cognitive outcome  
 for synostotic frontal plagiocephaly. J Neurosurg. Jul 2006;105(1 Suppl):16-20.
23.  Arnaud E, Renier D, Marchac D. Prognosis for mental function in scaphocephaly. J 
 Neurosurg. Sep 1995;83(3):476-479.
24.  Chieffo D, Tamburrini G, Massimi L, et al. Long-term neuropsychological development in   
 single suture craniosynostosis treated early. J Neurosurg Pediatr. Mar 2010;5(3):232-237.
25.  Marucci DD, Dunaway DJ, Jones BM, Hayward RD. Raised 1 intracranial pressure in Apert  
 syndrome. Plastic and reconstructive surgery. Oct 2008;122(4):1162-1168; discussion 1169- 
 1170.

Chapter 4
Audiological profile of children and young adults with 
syndromic and complex craniosynostosis
 
T. de Jong
M.S. Toll
H.H.W. de Gier
I.MJ. Mathijssen
Arch Otolaryngol Head Neck Surg. 2011 Aug;137(8):775-8
54
Chapter 4
ABSTRACT
Objectives To determine syndrome-specific type, severity, and prevalence of hearing 
loss to facilitate follow-up and treatment.
Design Tertiary pediatric hospital craniofacial clinic survey study. If insufficient or no 
data were available for a child, he or she was referred to an audiologist for puretone 
audiometry.
Setting Academic research facility.
Patients Information was gathered regarding 132 children and young adults with cra-
niosynostosis.
Main Outcome Measures The primary outcome was hearing assessment of children 
and young adults with various types of craniosynostosis. A secondary outcome was
inference regarding the incidence of otitis media among children and young adults 
with craniosynostosis.
Results We found mild or moderate hearing loss in 44.0% of patients with Apert syn-
drome, in 28.5% with Crouzon syndrome, in 62.1% with Muenke syndrome, in 28.6% 
with Saethre-Chotzen syndrome, and in 6.7% with complex craniosynostosis. Hearing 
loss was conductive in most patients with Apert, Crouzon, and Saethre-Chotzen syn-
dromes and it was predominantly sensorineural in patients with Muenke syndrome. 
Sensorineural hearing loss at lower frequencies was found only in patients with Muen-
ke syndrome.
Conclusions Most patients with syndromic and complex craniosynostosis have recur-
rent otitis media with effusion, causing episodes of conductive hearing loss throughout 
their lives. Sensorineural hearing loss can occur in all 4 syndromes studied but is the 
primary cause of hearing loss in children and young adults with Muenke syndrome. 
For patients with these syndromes, we recommend routine visits to the general practi-
tioner or otolaryngologist, depending on national standards of care, to screen for otitis 
media with effusion throughout life. We also advise early screening for sensorineural 
hearing loss among children and young adults with these syndromes.
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INTRODUCTION
Children with syndromic craniosynostosis are at high risk of developing hearing loss. 
An earlier retrospective study1 found that the prevalence of hearing loss varied from 
37% among children with Saethre-Chotzen syndrome to 72% among children with 
Apert syndrome. Despite the high prevalence, research on this topic is limited, espe-
cially for syndromes other than Apert syndrome. Current knowledge is based on data 
from few studies,2-6 with small sample sizes. Furthermore, only 1 study7 mentioned 
the severity of associated hearing loss. If syndrome-specific type, severity, and preva-
lence of hearing loss are known, appropriate follow-up and treatment can be imple-
mented. The best possible hearing is necessary to optimize language development, 
which is already compromised in many children with syndromic craniosynostosis.8
MEDTHODS
A cross-sectional survey was conducted among 146 patients aged 4 to 18 years with 
syndromic or complex craniosynostosis treated at the Dutch Craniofacial Center, Eras-
mus Medical Center–Sophia, Rotterdam, the Netherlands. All diagnoses were made 
by a geneticist based on the results of genetic analysis. If no syndrome diagnosis 
could be made and 2 or more sutures were closed, craniosynostosis was defined as 
complex. Because Crouzon and Pfeiffer syndromes often cannot be distinguished ge-
netically, we considered them a homogeneous group in this study. If no audiological 
information was available at our center, we contacted the parents or their child by 
mail to inquire about the results of testing performed elsewhere. In the Netherlands,
hearing screening is performed in the first week of life, in primary school, and in 
secondary school. If screening results are aberrant, the child will be referred to an 
otolaryngologist or audiologist. If a patient had been seen by an otolaryngologist or 
audiologist, informed consent was obtained to acquire audiological data. Information 
was gathered regarding audiometric results, episodes of otitis media, inserted ear 
plugs, and the use of hearing aids. If the patient never had been seen by an otolaryn-
gologist or audiologist, he or she was referred to an audiologist for single pure-tone 
audiometry. Patients were excluded if no audiological information was available and 
if they did not respond to or consent to our inquiry. A pure-tone average (with aver-
age losses at 0.5, 1.0, and 2.0 kHz) of 20- to 40-dB hearing loss was classified as mild 
and 41- to 70-dB hearing loss as moderate.
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RESULTS
Of 146 patients aged 4 to 18 years with syndromic or complex craniosynostosis, audi-
ological information was available at our center for 27 patients. The other 119 patients 
were contacted by mail, of whom 105 (88.2%) responded. Of 105 respondents, 62 had 
previously visited an otolaryngologist or audiologist and 43 had not. Of 43 who were 
referred for single pure-tone audiometry, we received information regarding 19 pa-
tients. The total group forwhomaudiological information was sought consisted of 132 
children and young adults (Table 1). Of these 132 children, 25 had Apert syndrome, 
42 had Crouzon syndrome, 29 had Muenke syndrome, 21 had Saethre-Chotzen syn-
drome, and 15 had complex craniosynostosis. The mean age at the time of review was 
11.5 years, and the mean age at the last hearing test was 8.8 years. Sixtysix patients 
(50.0%) were male. Of 132 children and young adults, 108 (81.8%) had been seen at 
least once by an otolaryngologist or audiologist, and 88 (66.7%) had undergone audi-
ometry at least once. Among those who underwent audiometry, 19 patients had Apert 
syndrome, 29 had Crouzon syndrome, 23 had Muenke syndrome, 10 had Saethre-
Chotzen syndrome, and 7 had complex craniosynostosis. The distribution of hearing 
loss severity in the ear with better hearing is given in the Table 1. The average hearing 
loss severity in the ear with better hearing across patients per frequency was calculated
for those with Apert, Crouzon, and Muenke syndromes (Figure 1). Audiological data 
were insufficient to calculate the frequency of hearing loss for patients with Saethre-
Chotzen syndrome and for those with complex craniosynostosis. Hearing loss in pa-
tients with Apert, Crouzon, and Saethre-Chotzen syndromes was mainly of conductive
origin. Hearing loss in patients with Muenke syndrome was mostly sensorineural at 
lower frequencies, sometimes occurring in combination with conductive hearing loss. 
This pattern of hearing loss was found only in patients with Muenke syndrome. Two 
patients with Saethre-Chotzen syndrome had unilateral sensorineural hearing loss, 
with pure-tone averages of 65- and 70-dB hearing loss. Recurrent otitis media with 
effusion was seen in 22 of 25 patients (88.0%) with Apert syndrome, 20 of 42 patients 
(47.6%) with Crouzon syndrome, 14 of 29 patients (48.3%) with Muenke syndrome, 
8 of 21 patients (38.1%) with Saethre-Chotzen syndrome, and none with complex 
craniosynostosis. Of 132 patients, 19 (14.4%) were treated with a hearing aid. These 
included 5 of 25 (20.0%) with Apert syndrome, 5 of 42 (11.9%) with Crouzon syn-
drome, 7 of 29 (24.1%) with Muenke syndrome, and 2 of 21 (9.5%) with Saethre-
Chotzen syndrome.
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Table 1 Severity of Hearing Loss in the Better Ear
Patient Group, No. (%)
Hearing loss Apert 
syndrome
(n=25)
Crouzon 
syndrome
(n=42)
Muenke 
syndrome
(n=29)
Saethre-Chotzen 
syndrome
(n=21)
Complex
craniosynostosis
(n=15)
None 14 (56.0) 30 (71.4) 11 (37.9) 15 (71.4) 14 (93.3)
Mild 6 (24.0) 8 (19.0) 14 (48.3) 6 (28.6) 1 (6.7)
Moderate 5 (20.0) 4 (9.5) 4 (13.8) 0 0
DISCUSSION
There is a high prevalence of hearing loss among children with syndromic craniosyn-
ostosis; this is reflected in the high proportion (66.7%) of patients who had visited
an otolaryngologist or audiologist at least once before this study. In most cases, recur-
rent otitis media with effusion has resulted in conductive hearing loss. Sensorineural
hearing loss or mixed hearing loss occurred in all syndromes but especially among 
patients with Muenke syndrome. If present, hearing loss in patients with Saethre-
Chotzen syndrome is mild and hearing loss is absent in most patients with complex 
craniosynostosis. Small studies2,9 show a high prevalence of congenital hearing loss 
due to ossicular chain fixation and constricted or absent external ear canals; larger 
studies3,7,10-12 show amuch lower prevalence of congenital hearing loss and indicate 
that recurrent otitis media with effusion is the main cause of conductive hearing loss 
in syndromic craniosynostosis. Several risk factors for the development of recurrent 
otitis media with effusion are present in patients with syndromic craniosynostosis, 
including small nasopharynx,13,14 short and dysfunctional eustachian tube,2,10,15 ob-
structive sleep apnea,16 and cleft palate.17 
 Apert syndrome is caused by an S252W or P253R mutation in the FGFR2 gene 
(OMIM 176943). This syndrome is characterized by craniosynostosis of coronal su-
tures, midface hypoplasia, obstructive sleep apnea, complex syndactyly of hands 
and feet, and mental retardation. Studies7,9,10,18,19 of patients with Apert syndrome 
describe a high incidence of conductive hearing loss, predominantly caused by recur-
rent otitis media with effusion and congenital stapes fixation. Superior semicircular 
channel dehiscence has been described in Apert syndrome as a cause of conductive 
hearing loss with larger air-bone gaps at lower frequencies.20,21 In effect, superior 
semicircular channel dehiscence creates a third window, which causes pseudocon-
ductive hearing loss. 
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Figure 1 Average hearing level in the better ear among patients with syndromic and 
complex craniosynostosis. Twenty-five with Apert syndrome (A); 42 with Crouzon 
syndrome (B); and 29 with Muenke syndrome (C). AC indicates air conduction thresh-
old; BC, bone conduction threshold.
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Crouzon syndrome is caused by several mutations in FGFR2 that differ from those in 
Apert syndrome. All sutures can be affected. Children with Crouzon syndrome have 
exophthalmus, midface hypoplasia, and a high prevalence of obstructive sleep apnea 
and raised intracranial pressure; however, their mental development is nearly normal 
in most cases. Among patients with Crouzon syndrome, studies2-4 describe conduc-
tive hearing loss, sensorineural hearing loss, and mixed hearing loss, caused by recur-
rent otitis media with effusion, ossicular chain fixation, and external auditory canal 
atresia. Although Crouzon syndrome has the lowest prevalence of hearing loss, 35.0% 
of patients have mild or moderate hearing loss. The same air-bone gaps as in Apert 
syndrome are seen, but they are larger at lower frequencies. Muenke syndrome is 
caused by a P250R mutation in FGFR3 (OMIM 134934). In most cases, 1 or 2 coronal 
sutures are affected. 
 Muenke syndrome is associated with a mild phenotype, but patients can have 
developmental and behavioral problems. A high prevalence of hearing loss is 
reported in Muenke syndrome, predominantly of the sensorineural type and worse 
at lower frequencies.11,22,23 Sensorineural hearing loss probably results from an influ-
ence of the FGFR3 mutation on development of the inner ear.24 This hearing loss 
was not found in patients with other forms of craniosynostosis, making it specific to 
Muenke syndrome. This is relevant for counseling; because the phenotype of Muenke 
syndrome varies, low-frequency sensorineural hearing loss may be the sole expres-
sion of the syndrome.
 Saethre-Chotzen syndrome has a mild phenotype and is caused by deletions 
or mutations in the TWIST1 gene (OMIM 601622). In most cases, coronal sutures are 
affected. This syndrome is characterized by ptosis of the upper eyelid. The literature 
pertaining to hearing in patients with Saethre-Chotzen syndrome is limited. A high 
prevalence of recurrent otitis media with effusion is described, and hearing loss (if 
present) was mostly conductive.5,11 One patient with Saethre-Chotzen syndrome
was described as having sensorineural hearing loss.6 Herein, 2 patients with Saethre-
Chotzen syndrome had unilateral sensorineural hearing loss, both of whom profited
from the use of a hearing aid. 
 The prevalence of hearing loss is low among patients with Saethre-Chotzen 
syndrome and among those with complex craniosynostosis. Because patients are 
routinely screened for hearing loss throughout their childhood, we can assume that 
they do not have clinically relevant hearing loss if they have never been examined by 
an otolaryngologist or audiologist. 
 Of the 108 children and young adults studied herein, only 19 were treated 
with a hearing aid, although more than 50% had mild or moderate hearing loss in 
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their better ear. This likely occurred because hearing loss is caused by recurrent otitis 
media with effusion in most instances and this condition was initially treated with 
grommets. Insertion of grommets does not prevent the development of permanent 
hearing loss, especially if ear discharge is present. Therefore, early management of 
hearing loss with a hearing aid always should be considered.19 Doing so will optimize 
auditory access and speech and language, since many developmental problems are
seen in children with these syndromes.8,22,25 
 In conclusion, regular checkups for middle ear function and hearing are in-
dicated at least until age 18 years for patients with Apert syndrome and those with 
Crouzon syndrome. Depending on national standards of care, these checkups can 
be performed by an otolaryngologist or general practitioner. Patients with persistent 
otitis media with effusion or significant hearing loss should be referred to an otolar-
yngologist. Patients with Apert, Crouzon, Muenke, and Saethre-Chotzen syndromes. 
should be screened for sensorineural hearing loss early in life. Treatment of hearing 
loss with grommets or hearing aids is needed in children and young adults with syn-
dromic craniosynostosis for optimization of speech and language development.
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ABSTRACT
Purpose We conducted this study to gauge the health-related problems, quality of 
life and the performance of the Health Utility Index Mark 3 (HUI-3) in patients with 
syndromic and complex craniosynostosis. Patients with syndromic and complex cra-
niosynostosis have various physical and mental problems. More insight on these 
problems, per syndrome, could provide guidance to improve patient treatment and 
follow-up. 
Methods A cross-sectional, comparative study on 131 patients and their parents was 
performed. Health-related quality of life was measured with the HUI-3 and the Visual
Analogue Scale (VAS). All data were compared to a normative Dutch population. Vi-
sion, hearing and intelligence were objectively measured. 
Results The HUI-3 and the VAS were significant lower compared to the normative 
Dutch population. All syndromes have a high prevalence of vision and speech prob-
lems. Cognitive problems were mainly reported in patients with Apert, Crouzon and 
Muenke syndrome. Ambulation and dexterity problems were seen in Apert, Crouzon, 
Saethre–Chotzen and complex craniosynostosis. Only patients with Apert syndrome
scored significantly worse on pain. The HUI-3 had a medium to strong correlation 
with the objectively measured outcomes.
Conclusions The overall quality of life is lower in patients with syndromic and com-
plex craniosynostosis. To improve quality of life, more attention is needed for prob-
lems with vision and speech.
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INTRODUCTION
Craniosynostosis involves the premature closure of the cranial sutures. In about 40% 
of the patients, it is part of a syndrome such as Apert, Crouzon, Muenke and Saethre–
Chotzen. Patients with syndromic and complex craniosynostosis have a lower health 
related quality of life (HRQoL), while patients with isolated craniosynostosis score 
within the normal range for quality of life and behavioral problems.1 Reasons for the 
lower HRQoL are problems concerning physical functioning, bodily pain and mental 
health.2 Commonly reported healthrelated problems in syndromic craniosynostosis 
are hearing and visual disorders, sleep apnea and hand and foot anomalies.3 The 
prevalence and severity of these problems vary per syndrome, and it is unknown to 
what extent they influence the HRQoL and parents perceived quality of life. The aim 
of this study was to evaluate health related problems, quality of life and the perfor-
mance of the Health Utility Index Mark 3 (HUI-3) in patients with syndromic cranio-
synostosis.
MATERIAL AND METHODS
A cross-sectional comparative study was performed in patients 4–18 years of age, 
with a diagnosis of syndromic or complex craniosynostosis. All patients were treated 
at the craniofacial unit of a tertiary pediatric hospital. Patients were included in the 
study if they had craniosynostosis associated with Apert, Crouzon, Pfeiffer, Saethre–
Chotzen, Muenke syndrome or complex craniosynostosis. Syndrome diagnosis was 
based on genetic testing. Complex craniosynostosis was defined as the premature 
closure of two or more sutures in the absence of a genetic mutation. Because Crou-
zon and Pfeiffer syndrome cannot be distinguished from each other genetically, they 
were considered a homogeneous group in this study. The health-related quality of 
life was assessed using the HUI-3 questionnaire.4-5 The HUI is developed to measure 
health-related quality of life and is applicable in clinical studies. The HUI is suitable for 
patients of 5 years and older, and for children under the age of 8 years a proxy assess-
ment is recommended. Because we approached a large group of patients younger 
than 8 years and there is a high prevalence of cognitive impairment in patients with 
syndromic craniosynostosis, we requested the parents to complete the question-
naire. Patients were compared to normative data from a general Dutch population 
survey.6 It were also the parents who completed the questionnaire in the Dutch popu-
lation survey. Based on the questionnaire, subjects were classified according to the 
HUI-3 classification system. The HUI is a utility (preference) based scoring system for 
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measuring comprehensive health status and health-related quality of life, consist-
ing of eight attributes. Each attribute was scored from 1 (no limitations) to 4, 5 or 
6 (severe limitations). Single attribute utility scores range from 1.00 to 0.00, where 
perfect health is 1.00 and dead is 0.00. Multi-attribute utility scores, indicating over-
all health, are calculated based on single attribute scores.7-8 The multi-attribute HUI 
score can be negative, which indicates a state described as worse than dead. Next to 
the HUI, the Visual Analogue Scale (VAS) was used to rate parent-perceived overall 
health of the child, with a score ranging from 0 (worst health) to 100 (best health). 
The questionnaire was once sent by mail once. From the eight attributes of the HUI-3, 
vision, hearing and intelligence can be measured objectively. Therefore, we collected 
data of vision, hearing and intelligence to compare to the corresponding HUI-3 attri-
butes. Data of vision was retrospectively collected. Vision is routinely checked with a 
Snellen chart by our pediatric ophthalmologist. Data of hearing was cross-sectionally 
gathered as part of another study.9 Hearing was tested by a pediatric audiologist with 
pure tone audiometry. Hearing loss was expressed as the average hearing loss at 500, 
1.000 and 2.000 Hz of the best ear. Intelligence was tested by a pediatric psychologist 
with the Wechsler Intelligence Scale for Children (WISC)-III, as part of a prospective 
study. 
Statistical analysis
Mann–Whitney U-test was used to compare means within the syndrome groups and 
between the syndrome groups and the normative population. Pearson’s chi-square 
test was used to test correlation. A two-sided p≤0.05 was considered significant. All 
analyses were performed using SPSS 16.0 (SPSS Inc., Chicago, IL, USA).
RESULTS
A total of 173 patients were approached, of whom 131 responded (76%). Of the 131 
patients, 20 had Apert, 39 Crouzon/Pfeiffer, 25 Muenke, 18 Saethre–Chotzen and 29 
complex craniosynostosis. The mean age of the patients at the time of this review was 
9.6 years, and 45% were female. The average age of the respondents was 41.6 years, 
and 73% were female (see Table 1). There was no significant difference between how
mothers and fathers scored the HUI-3 and VAS, in the normative Dutch population 
and craniosynostosis groups. Age and gender did not influence quality of life, except 
for Apert syndrome, were the males had a significant lower HUI-3. The percentage of 
patients who are not affected and the mean single attribute HUI-3 scores are shown 
in Table 2. Patients were considered to be not affected if they had the best possible 
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score for that specific attribute. Vision, speech and cognition were the most affected 
attributes in patients with syndromic craniosynostosis. Speech was significant associ-
ated with hearing (p<0.001) and cognition (p<0.001). The mean VAS and multi-attri-
bute HUI-3 score are shown in Table 3. There was no significant difference between 
the multi-attribute score and the VAS except for the Apert syndrome, in whom the 
HUI-3 was significant lower. This difference indicates that parents subjectively experi-
ence a higher quality of life for their child than their objective scoring indicates. The 
correlation between the multi-attribute HUI-3 and the VAS was 0.476 (p<0.001) in 
patients with craniosynostosis. Of the 131 included patients, 68 (52%) had data on vi-
sion, 63 (48%) on hearing and 60 (46%) were tested with the WISC-III. The correlation 
between the objective measurements and the single-attributes was 0.558 (p<0.001) 
for vision, −0.345 (p=0.006) for hearing and 0.418 (p=0.001) for intelligence.
Table 1 Characteristics of patients and the normative population
Apert
(n=20)
Crouzon
(n=39)
Muenke
(n=25)
Saethre-
Chotzen
(n=18)
Complex
(n=29)
Norm group
(n=1435)
Sex patient M/F 8/12 18/21 11/14 5/13 17/12 708/727
Age patients in 
years, mean (sd)
10.6 (4.9) 9.5 (3.9) 9.3 (4.1) 10.4 (3.9) 8.7 (4.0) 8.1 (2.4)
Sex parent M/F 6/14 9/30 6/19 4/14 7/22 206/1229
Age parent in 
years, mean (sd)
41.6 (8.0) 41.8 (5.3) 40.5 (6.3) 43.3 (7.9) 41.3 (6.0) 37.7 (5.2)
DISCUSSION
The multi-attribute HUI-3 and the VAS are significantly lower in patients with cranio-
synostosis compared to the normative Dutch population. Themain reasons for this 
are problems with vision and speech, and cognition in Apert and Crouzon syndrome.
Ambulation, emotional problems and pain have no or limited influence on the HRQoL 
in syndromic craniosynostosis. In general, age and gender did not influence the qual-
ity of life. The overall correlation between the objective measurements and the HUI-3 
attributes is medium to strong. Most problems were found in the attributes vision,
speech and cognition, despite routine screening for these impairments in our pa-
tients. This screening and treatment is thus essential but cannot prevent or overcome 
all restrictions. Problems with vision affect about half the patients and can be 
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due to refractive error, strabismus, astigmatism and persistent elevated intracranial 
pressure.10-13 Speech problems have previous been reported in Apert, Muenke and 
Saethre–Chotzen syndrome.14-16 Causes for speech problems are hearing deficits, oral 
anomalies, learning disabilities and impaired social interaction.16 The impaired cog-
nition is probably not the main reason for speech problems but will contribute to a 
worse language development.16 The level of intelligence varies strongly per syndrome 
but also within every syndrome, especially patients with Apert syndrome can have a 
low intelligence.17-20
 The single-attribute HUI-3 had a medium to strong correlation with the objec-
tively measured vision, hearing and intelligence. However, in individual cases, there 
were large differences between how parents scored the vision, hearing or intelligence 
and the objective measurements. It is known that parents have difficulty judging their 
child’s hearing.21 Therefore, we conclude that the HUI-3 is less suitable in individual 
patients for follow-up, but can be used on a group level for patients with syndromic 
craniosynostosis. A limitation of this study is that although this is one of the largest 
reported groups of children with syndromic craniosynostosis, the syndrome-specific 
groups still have a small sample size, making comparisons within groups not more 
than explanatory. Another limitation is the crosssectional design of this study. In con-
clusion, the overall quality of life is lower in patients with syndromic and complex cra-
niosynostosis. To improve quality of life more attention is needed for problems with 
vision and speech. As there can be a big discrepancy between objective measures 
and how parents score the HUI-3, this questionnaire is more suitable for groups than 
for individual follow-up. The Erasmus Medical Center medical ethical review board 
approved the study under reference number: MEC-2005-273.
Table 3 Mean multi-attribute score of the HUI-3 and VAS
HUI-3 VAS
Apert (n=20), mean (SD) 0.44* (0.30) 0.77 (0.20)
Crouzon (n=39), mean (SD) 0.76 (0.23) 0.79 (0.18)
Muenke (n=25), mean (SD) 0.81 (0.22) 0.81 (0.16)
Saethre–Chotzen (n=18), mean (SD) 0.87 (0.14) 0.88 (0.11)
Complex (n=29), mean (SD) 0.83 (0.24) 0.87 (0.10)
Total craniosynostosis group (n=132), mean (SD) 0.75 (0.27)± 0.82 (0.16)±
Norm group (n=1435), mean (SD) 0.91 (0.12) 0.93 (0.09)
*Significantly lower compared to VAS, p<0.05
±Significantly lower compared to norm group, p<0.001
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Table 2 M
ean single-attribute H
U
I-3 of patients and the norm
ative population
A
pert 
(n=20)
C
rouzon
(n=39)
M
uenke
(n=25)
Saethre-C
hot-
zen
(n=18)
C
om
plex
(n=29)
N
orm
 group
(n=1435)
%
 not
affected
M
ean
%
 not
affected
M
ean
%
 not
affected
M
ean
%
 not
affected
M
ean
%
 not
affected
M
ean
%
 not
affected
M
ean
V
ision
50
0.90
 ±
50
0.90
 ±
60
0.97
 ±
31
0.96 ±
72
0.99 ±
93
0.99
H
earing
85
0.93 ±
79
0.93
 ±
76
0.93 ±
89
0.96
#
93
0.98
*
98
1.00
Speech
20
0.68
 ±
56
0.84
 ±
56
0.84 ±
71
0.95
*
66
0.87 ±
88
0.97
A
m
bulation
85
0.97
 ±
90
0.96
 ±
100
1.00
100
1.00
93
0.96 ±
99
1.00
D
exterity
0
0.58
 ±
90
0.95
 ±
100
1.00
94
0.98
#
93
0.96 ±
99
1.00
E
m
otion
80
0.97
 
71
0.97
71
0.97
76
0.98
83
0.98
81
0.98
C
ognition
25
0.77
 ±
61
0.93
 ±
72
0.89
*
78
0.97
72
0.94
84
0.97
Pain
55
0.93
 ±
73
0.97
76
0.96
76
0.98
79
0.97
81
0.98
*p<
0.05, #p<
0.01, ±p<0.001 com
pared to norm
 group
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ABSTRACT
Background Apert syndrome is a rare condition characterized by craniosynostosis, 
cerebral anomalies, complex syndactyly of hands and feet, and a low to near nor-
mal mental development. There are no reports on long-term outcome of upper and 
lower extremity, and the impact on quality of life. The aim of this study is to report 
on activity limitation of the upper and lower extremity, and its impact on quality of 
life in patients with Apert syndrome.
Methods Questionnaires were sent to all patients of 6 years and older. Patients from 
6 until 16 years received the Abilhand-Kids, Lower Extremity Functional Scale (LEFS), 
Child Health Questionnaire Parental Form 50 (CHQ-PF50), and Health Utility Index 
(HUI)-3. Patients aged 16 years or older received the Disabilities of the Arm, Shoul-
der, and Hand (DASH) Questionnaire, LEFS, and Short Form 36 health survey (SF-36). 
All patients received a Visual Analogue Scale (VAS) to grade overall health, function 
and appearance of the hands. Results were compared to normative data from the 
literature, also the correlation between activity limitation and quality of life was 
tested.
Results Forty of the 45 eligible patients (response rate 89%) returned the question-
naires. Patients with Apert syndrome scored significantly lower compared to nor-
mative data. However, more than 60% of the patients with Apert syndrome scored 
within the normal range for the SF-36, CHQ-PF50, VAS quality of life and the DASH. 
A lower limitation of activity was associated with a higher quality of life. Activity 
limitations of the upper and lower extremities had a similar relation with quality of 
life. Caregivers scored similar compared to persons with Apert syndrome for quality 
of life but significantly lower for activity limitation (p<0.01).
Conclusions  More than 60% of the patients with Apert syndrome and their caregiv-
ers report a quality of life and activity limitation within the normal range. However, 
about one-third of the patients may perceive a low quality of life and high activity 
limitation. A higher limitation of activity should be considered as a risk factor for a 
lower quality of life in these patients.
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INTRODUCTION
Apert syndrome is a rare condition affecting around 1 in every 65.000 live birth, 
characterized by craniosynostosis of the coronal sutures, cerebral anomalies, mid-
face hypoplasia, symmetric complex syndactyly of hands and feet, and a low to near 
normal mental development. In more than 98% of the cases it is caused by a S252W 
or P253R mutation in the FGFR2 gene.1 2-3 The mode of transmission is autosomal 
dominant, but almost all cases are sporadic. Most of the de novo mutations occur 
during spermatogenesis and are related to an advanced paternal age.4 
 The commonly used classification system of the hand anomalies in Apert 
syndrome is that of Upton,5 classifying the Apert hand into three types according 
to increasing severity; type I hands (“spade hand”) consist of complex syndactyly 
of digits two through four with a free thumb and a simple syndactyly of the fourth 
web, or a separate fifth finger; type II hands (“mitten or spoon hand”) consist of 
complex syndactyly of digits two through five with an associated simple (incom-
plete) syndactyly of the thumb; and type III hands (“rosebud hand”) consist of com-
plex syndactyly of all digits. In all cases a brachyclinodactyly of the thumb is present. 
Furthermore a synostosis between the fourth and fifth metacarpal bones can be 
possible. The P253R mutation is associated with the more severe complex syndac-
tyly of the hands.6-7
 The feet in Apert syndrome are characterized by a medial deviation of the 
great toe and fusion of the two phalanges with a minimal motion at the metatarso-
phalangeal joint. The midfoot and hindfoot will characteristically fuse in a supinated 
position. There is prominence of the fifth and third metatarsal heads with callus 
formation in most patients.8 
 Besides complex syndactyly of hands and feet, other malformations of the 
extremities may occur. These may be present at birth or manifest at a later age. In 
the upper extremity this results in limited shoulder anteflexion and abduction.9 El-
bow motion is mostly not a significant problem unless elbow fusion (9%) occurs.10-11 
In the lower extremity, acetabular, femoral head and neck alterations, and genua 
valga are incidentally reported, causing limitations of activity.11
 Previously, two studies from our department have demonstrated a lower 
quality of life in patients with Apert syndrome compared to other craniosynostosis 
syndromes and normal controls.12-13 They found that parents reported problems 
specifically regarding vision, speech, dexterity and cognition measured with the 
Health Utility Index-3 (HUI-3). Furthermore, lower scores for physical functioning, 
parental impact and family activities measured with the Child Health Questionnaire 
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Parental Form 50 (CHQ-PF50) have been reported. Lower scores on dexterity and 
physical functioning are probably the result of activity limitations of the extremities. 
Apert syndrome has various effects on a person’s functioning and well-being. There-
fore, knowing the impact of this syndrome on physical functioning and quality of 
life is clinically important. To our knowledge scientific reports on patients with 
Apert syndrome have mainly focussed on surgical techniques and short-term out-
come. However, no reports have been published on long-term outcome of physical 
functioning of the upper and lower extremities, and the impact on quality of life in 
patients with Apert syndrome. Therefore the aims of this study are to 1) report on 
perceived physical functioning of the upper and lower extremities, and quality of life 
in patients with Apert syndrome of 6 years or older, and 2) present data which can 
be employed for comparison in future surgical and non-surgical research.
METHODS
We performed a cross-sectional study in patients with Apert syndrome treated for 
their hand differences at the Sophia’s Children’s Hospital of the Erasmus MC Univer-
sty Medical Center (Rotterdam, the Netherlands). Questionnaires were sent through 
mail to all patients aged 6 years and older. Caregivers of 6-16 years-old patients 
were asked to complete the Abilhand-Kids, Lower Extremity Functional Scale (LEFS), 
Child Health Questionnaire Parental Form (CHQ-PF50) and Health Utility Index 
(HUI)-3. Patients of 16 years and older were asked to complete the Disabilities of 
the Arm, Shoulder, and Hand (DASH) Questionnaire, LEFS, and Short Form 36 health 
survey (SF-36). In all patients a Visual Analogue Scale (VAS) was used to grade 
overall health, function and appearance of the hands. In patients aged 6-16 year all 
questionnaires were completed by a caregiver. When patients aged >16 years expe-
rienced difficulty completing the questionnaires, they were filled out with help of a 
caregiver or by a caregiver alone.
Questionnaires (Table 1)
The Abilhand-Kids evaluates a child’s manual ability in bimanual activities per-
formed by patients aged 6-15 years.14-15 This questionnaire is developed for children 
with cerebral palsy, no normative data are present in the current literature. It mea-
sures the parent’s perceptions of the difficulty in performing a bimanual daily activ-
ity on a three level scale: impossible (0), difficult (1), easy (2). The sum score range is 
0-42. A higher score indicates lower difficulty. 
 The DASH is designed to measure physical functioning and symptoms of the 
upper extremities in persons 18 till 65 years of age.16 Normative data are available 
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for the general American population.17 For each question, patients or caregivers 
were asked to provide their perceived difficulty in performing an activity on a five 
level scale: no difficulty (1), mild difficulty (2), moderate difficulty (3), severe diffi-
culty (4) and unable (5). The sum score range is 0-100, with higher scores indicating 
greater disability.18
 The LEFS measures overall function of the lower extremities. The question-
naire consists of 20 questions. For each question, patients or caregivers were asked 
to provide their perceived difficulty on five level scale: extreme difficulty or unable 
to perform activity (0), quite a bit of difficulty (1), moderate difficulty (2), a little bit 
of difficulty (3) and no difficulty (4). The range of the total score is 0-80, with higher 
scores indicating better function.19 Normative data are missing in the current litera-
ture.
 The CHQ-PF50 is a generic health survey that measures parental perception 
of their child’s overall health and is appropriate for parents or caregivers of patients 
5-18 years of age. Dutch normative data are available.12 It contains 12 health-do-
mains and gives a summary score for physical and psychosocial functioning. Scales 
have a mean of 50, with a standard deviation of 10. Higher scores indicate a higher 
level of well-being.
 The SF-36 is a short generic health survey, designed for adults for which 
Dutch normative data are available.20 It measures 8 health domains and gives a sum-
mary score for the physical and mental component. Scales range from 0 to 100 with 
higher scores indicating higher level of well-being.
 The HUI-3 is a utility or preference-based scoring system added to the survey 
to measure health-related quality of life. This questionnaire is suitable for patients 
of 5 years and older. Dutch normative data are available for children aged 5 to 13 
years of age.21-22 Single attribute utility scores range from 0.00 to 1.00, where per-
fect health is 1.00 and dead is 0.00. The multi-attribute HUI score can be negative, 
indicating states described as worse than dead.23 
 The VAS is a line from 0 “not affected” to 100 “severely affected”. Patients 
were asked to put a point on the line corresponding to how they felt to be affected.
If 10% of the items of any scale were missing, that individual’s scale score was 
treated as missing values.
Statistical analysis
Differences between patients and caregivers were tested with the Mann-Whitney U 
test. The student-t test was used to compare our results to normative data from the 
literature. The correlation between different questionnaire outcomes was assessed 
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with the Spearman correlation coefficient. The correlation was considered to be 
small with a rho of 0.3-0.5, moderate with a rho of 0.5-0.8 and strong with a rho 
of ≥0.8. A two-sided p-value of 0.05 or smaller was considered to be significant. All 
analyses were performed in SPSS 16.0 for windows.
Table 1 Summary of the questionnaires
Measures Best score Worst 
score
6-16 year > 16 year
Abilhand-
Kids
bimanual ability 42 0 x -
LEFS overall function of 
the lower extremity
80 0 x x
CHQ-PF parental perception 
of their child’s ge-
neric quality  of life
100 0 x -
SF-36 generic quality of 
life
100 0 - x
HUI-3 health-related qual-
ity of life
1.0 -0.37 x x
VAS overall health, func-
tion and appearnace 
of the hands
100 0 x x
RESULTS
The database consisted of 59 patients, of whom 6 were too young to participate, 3 
deceased and 5 were lost to follow up. Of the 45 eligible patients for this study, 40 
(89%) returned the questionnaires. Non-responders were not different regarding 
age (p=0.71) and gender (p=0.23). Since 5 patients did not participate in the study, 
only age and gender were known. Severity of the Apert syndrome or education 
could therefore not be compared. Patient characteristics are presented in Table 
2. Of the 24 patients aged > 16 year, 11 (56%) completed the questionnaire them-
selves, 5 (21%) with help of a caregiver and 8 (33%) were solely completed by a 
caregiver. Several caregivers reported difficulties with answering the questionnaires 
because they found that a number of activities were not applicable due to physical 
or mental impairment of their child. As a result, missing data were present in these 
instances.
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Table 2 patient characteristics
Age, mean ± sd, range (y) 21.6±10.4 (6.1-53.6)
        Age 6-16 y, n (%) 16 (40%)
        Age > 16 y, n (%) 24 (60%)
Sex, n (%)
        Male 15 (38%)
        Female 25 (62%)
Hand surgery
        All hand surgery performed    
        in our centre
24 (60%)
        Surgery elsewhere 16 (40%)
Work status (patients aged >16 y), n 
(%) 
        Student 1 (4%)
        Part- or full-time job 10 (42%)
        Unemployed 13 (54%)
Quality of life
Sum scores of the quality of life questionnaires are presented in Table 3. For the 
patients aged >16 year, patients (n=11) and caregivers (n=8) scored similar on the 
SF-36 but patients scored significant higher on the HUI-3, median 0.80 versus 0.52 
(p=0.004).  Quality of life was significantly lower compared to normal controls, ex-
cept for the SF-36 mental sum score, which was significant higher. For the results of 
all domains of the quality of life questionnaires see Appendix 1, 2 and 3. 
Activity limitation
Outcomes of the activity questionnaires are presented in Table 4. In patients aged ≥ 
16 year, patients (n=11) scored a significant lower limitation of activity compared to 
caregivers (n=8); DASH (12.5 versus 50.0, p=0.006), VAS hand function (80 versus 45, 
p=0.005) and LEFS (75 versus 56, p=0.008). This comparison could not be made for 
patients aged 6-16 years because all questionnaires were answered by caregivers.
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Relations between different questionnaires
In the 6-16 year group the Abilhand-Kids and the LEFS had a moderate to strong 
correlation with the HUI-3 and the CHQ-PF50 (Table 4). For the patients >16 years 
the DASH and LEFS had a moderate to strong correlation with the HUI-3 and a weak 
correlation with the SF-36 (Table 5). 
Table 3 Quality of life questionnaires
6-16 years > 16 years
Apert
Mean (sd), % in 
normale rangea
n=16
Normative 
data
Mean (sd)
Apert
Mean (sd), % in 
normale rangea
n=24
Normative 
data
Mean (sd)
HUI-3 Multi-
attribute score
0.53 (0.3)*, 33% 0.93 (0.1) 0.60 (0.3) -
SF-36
        Physical - - 47.80 (7.2)*, 89% 54.02 (6.9)
        Mental - - 55.53 *(8.3)#, 100% 49.78 (9.2)
CHQ-PF50
        Physical 44.9 (15.8)*, 71% 56.4 (5.7) - -
        Psychosocial 47.8 (5.3)#, 93% 53.2 (6.4) - -
VAS general 
health
72.3 (27.3)*, 64% 92.7 (9.2) 81.0 (20.5) -
a Percentage of patients with scores > mean -2sd of the normative data
* p<0.001, #p<0.01 compared to normative data
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Table 4 Questionnaires of upper and lower extremity
6 - 16 years
Mean (sd)
> 16 years
Mean (sd)
Apert 
n=16
Apert
Mean (sd), % in 
normale rangea
n=24
Normative data
Mean (sd)
Abilhand-Kids 24.9 (11.8) - -
DASH - 29.0 (19.0)*, 68% 10.1 (14.7)
VAS hand function 61.7 (24.7) 68.3 (25.5) -
VAS hand appear-
ance
64.3 (22.8) 62.8 (27.3) -
LEFS 60.0 (16.4) 60.9 (19.2) -
a Percentage of patients with scores > mean -2sd of the normative data
*p<0.01 compared normative data
Table 5 Correlation between QoL and activity limitation*
DASH Abilhand-Kids LEFS
HUI3 multi-attri-
bute
0.84c 0.63b 0.87c
SF-36 physical 0.47b - 0.40a
CHQ-PF50 physical - 0.73b 0.76c
*Correlation expressed as Spearman’s rho (absolute value)
a not significant, b p<0.05, c p<0.001
DISCUSSION
 In this study on 40 persons with Apert syndrome we found a significantly lower 
score compared to normative data on quality of life (HUI-3, SF36, CHQ-PF, VAS) and 
significantly more on activity limitation (DASH). Despite this, approximately 60% of 
the participants reported a quality of life and activity limitation within the normal 
range. More severe activity limitation was associated with lower quality of life. 
 It is clinically important to know the long-term functioning of persons with 
Apert syndrome. This information is helpful in parental counselling. Parents should 
be informed that despite the severe hand and feet anomalies, individual patients 
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can achieve a good long-term ability and/or quality of life. To our knowledge we are 
the first to report on long-term functioning of the extremities regarding quality of 
life and activity limitation in Apert syndrome. Therefore it is not possible to compare 
our results with those of other investigators. 
 We found a difference in reporting activity limitation between patients and 
caregivers.  This might be explained by the fact that patients who completed the 
questionnaires themselves, depending on age, will probably have a higher intelli-
gence. Patients with Apert syndrome can have intelligence within the normal limits, 
but it can also be severely compromised, about one third has an IQ above 70.24-26 In 
patients with myelomeningocele a positive relation between intelligence and hand 
function was found.27 If intelligence differed between the two groups, patients with 
a higher intelligence could have scored a better hand function while the severity of 
the impairment might be similar to those with a lower intelligence. Another expla-
nation could be the disability paradox, which describes that people with a serious 
disability experience their disability as less severe compared to most people without 
a disability.28 This might have led to an overestimation of the limitation of activity 
when caregivers completed the questionnaires.
 The results of the CHQ-PF50 and the VAS general health were comparable 
with our previous studies, while the HUI3 was considerably better in this study.12-13 
The results of the HUI3 could be higher due to the disability paradox, because the 
previous study results are only based on parental reports. No differences were 
found in the other quality of life questionnaires between patients and their caregiv-
ers, while previous studies report a difference between how parents and children 
report quality of life,29-30 this difference could go both ways.30 All mean quality of life 
scores were considerably lower compared to data from the normal Dutch popula-
tion, except for the SF-36 mental summary score.11, 23 This suggests that patients 
with Apert syndrome do not experience much stress and are happy in general. 
 Although this is a cross-sectional study, the results imply a relation between 
activity limitation and quality of life in patients with Apert syndrome. Based on the 
results in Table 5 we may conclude that a lower limitation of activity is associated 
with a higher quality of life and that activity limitations of the upper and lower 
extremities have a similar relation with quality of life. Furthermore, the CHQ-PF50 
seems to have a better responsiveness for upper and lower extremity activity 
limitation than the SF-36. This difference may be due to the experienced difficulty 
in answering the questionnaires; several caregivers found that at least some of the 
activities were not applicable, due to physical or mental impairment of their child. 
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Study limitations
There are several limitations of this study. Firstly, used questionnaires may not be 
sensitive to all problems encountered in Apert syndrome. This is strengthened by 
caregivers who reported difficulties in answering questions not applicable for their 
child. Secondly, DASH, Abilhand-kids and LEFS mainly measure activity limitation. 
Objective measurements of severity of impairment and participation are missing. 
Thirdly, because it is a cross-sectional study; a prospective study is needed to mea-
sure the effect of hand surgery on activity limitation and quality of life. Fourthly, we 
had no objective data of intelligence of these patients. Intelligence will have a large 
influence on quality of life and participation. These topics should be addressed in 
future research.
Conclusion
More than 60% of the patients with Apert syndrome report a good quality of life 
and low limitation of activity. However, individual patients will obtain a very low 
quality of life and high activity limitation. The presence of a more severe activity 
limitation should be considered as a risk factor for lower quality of life. Activity limi-
tation of upper and lower extremity have a similar impact on quality of life. 
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APPENDIX
Appendix 1 HUI3 domains
6 - 16 years
Median (range)
> 16 years
Median (range)
Vision 0.95 (0.38 - 1.0) 0.95 (0.0 - 1.0)
Hearing 1.0 (0.86 - 1.0) 1.0 (0.71 - 1.0)
Speech 0.82 (0.41 - 1.0) 0.91 (0.0 - 1.0)
Ambulation 1.0 (0.83 - 1.0) 1.0 (0.36 - 1.0)
Dexterity 0.36 (0.0 - 1.0) 0.67 (0.0 - 1.0)
Emotion 1.0 (0.73-1.0) 1.0 (0.91 - 1.0)
Cognition 0.86 (0.32 - 1.0) 0.86 (0.32 - 1.0)
Pain 1.0 (0.48 - 1.0) 1.0 (0.77 - 1.0)
HUI3 multi-attribute 0.47 (0.09 - 0.91) 0.60 (-0.2 - 1.0)
Appendix 2 CHQ-PF50 domains
6 - 16 years
Median (range)
Physical summary 49.1 (2.3 - 61.3)
Psychosocial summary 48.8 (39.8 - 57.6)
physical functioning 88.9 (33.3 - 100)
Role functioning: emotional/behaviour 72.2 (0 - 100)
Role functioning: physical 91.7 (0 - 100)
Bodily pain 80 (20 -100)
General behaviour 80.8 (30-89.2)
Mental health 70 (30 - 90)
Self-esteem 70.8 (58.3 - 83.3)
General health perceptions 45.4 (13.3 - 91.7)
Parental impact: time 88.9 (0 - 100)
Family activity 87.5 (16.7 - 100)
Family cohesion 85 (57.5 - 100)
Change in health 50 (0 - 100)
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Appendix 3 SF-36 domains
> 16 years
Median (range)
Physical component summary 49.7 (26.8 - 55.6)
Mental component summary 58.4 (37.6 - 64.8)
Physical functioning 75 (10 - 100)
Role physical functioning 100 (0 - 100)
Bodily pain 90 (41 - 90)
General health perceptions 70 (40 - 90)
Vitality 75 (45 100)
Social functioning 100 (62.5 - 100)
Role functioning: emotional 100 (0 - 100)
Mental health 84 (40 - 100)
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ABSTRACT
Purpose Brain abnormalities in patients with syndromic craniosynostosis can either 
be a direct result of the genetic defect or develop secondary to compression due 
to craniosynostosis, raised ICP or hydrocephalus. Today it is unknown whether chil-
dren with syndromic craniosynostosis have normal brain volumes. The purpose of 
this study was to evaluate brain and ventricular volume measurements in patients 
with syndromic and complex craniosynostosis. This knowledge will improve our un-
derstanding of brain development and the origin of raised intracranial pressure in 
syndromic craniosynostosis. 
Methods Brain and ventricular volumes were calculated
from MRI scans of patients with craniosynostosis, 0.3 to 18.3 years of age. Brain vol-
ume was compared to age matched controls from the literature. All patient charts 
were reviewed to look for possible predictors of brain and ventricular volume.
Results Total brain volume in syndromic craniosynostosis equals that of normal con-
trols, in the age range of 1 to 12 years. Brain growth occurred particularly in the first
5 years of age, after which it stabilized. Within the studied population, ventricular 
volume was significantly larger in Apert syndrome compared to all other syndromes 
and in patients with a Chiari I malformation. 
Conclusions Patients with syndromic craniosynostosis have a normal total brain vol-
ume compared to normal controls. Increased ventricular volume is associated with 
Apert syndrome and Chiari I malformations, which is most commonly found in Crou-
zon syndrome. We advice screening of all patients with Apert and Crouzon syndrome 
for the development of enlarged ventricle volume and the presence of a Chiari I mal-
formation.
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INTRODUCTION
Children with craniosynostosis develop an abnormal head shape due to the prema-
ture closure of one or more cranial sutures. This congenital malformation occurs in 
one in 2100 to 2500 births. In up to 20% of these cases it is part of a syndrome, such 
as Apert, Crouzon, Muenke and Saethre-Chotzen, caused by mutations in the  FGFR1, 
2 and 3 and TWIST1 gene.1 Different brain abnormalities are reported in patients 
with syndromic craniosynostosis including non-progressive ventriculomegaly, callosal 
agenesis or thinning, agenesis of the septum pellucidum, paucity of the antero-me-
sial temporal white matter, medial temporal lobe dysgenesis, pyramidal hypoplasia, 
venous malformations and Chiari I malformations.2-8 In patients with syndromic cra-
niosynostosis the origin of the abnormalities can either be intrinsic to the genetic de-
fect or develop secondary to the craniosynostosis and associated hydrocephalus and 
increased intracranial pressure (ICP). A mismatch between intracranial volume versus 
brain and ventricle volume is thought to be one of the causes of brain abnormalities 
and elevated ICP. However, in spite of the craniosynostosis the intracranial volumes 
are reported to be normal in patients with craniosynostosis or even enlarged in Apert 
and Crouzon syndrome.9-11 Only one study reports on brain volume in syndromic cra-
niosynostosis. They found that patients with Crouzon syndrome had a similar brain 
volume compared to normal controls.12 This contradicts the assumption that a mis-
match between intracranial and brain volume is the cause of raised ICP. To improve 
our understanding of the development of raised ICP, knowledge of brain and ven-
tricular volume in this population is needed.
MATERIAL AND METHODS
Patients diagnosed with syndromic or complex craniosynostosis based on genetic 
testing and treated at the Dutch craniofacial center were invited to undergo MRI. 
Craniosynostosis was defined as complex if two or more sutures were closed and no 
mutation was found. The MRI were performed on a 1.5-T MR scanner (GE Health-
care, MR signa excite HD) between January 2004 and January 2011. Brain and ven-
tricular volumes were calculated from the transversal 3D T1 weighted MR images 
with the use of Brainlab®. This is a post-processing programme developed for neu-
ronavigation. The software automatically outlines the brain and ventricle contour in 
each slice. If the automatic contour was questionable, it was manually edited. After 
outlining the brain or ventricle volume slice by slice, the processing programme au-
tomatically computes the total volume. The within-rater and between-rater reliabili-
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ties were 0.99 and 0.97 respectively. Brain volume was compared to that in normal 
controls at the age of 1, 4, 8 and 12 years, reported in literature.13-15 Total ventricle 
volume could not be compared to that of normal controls because of the lack of 
normative data in the literature. A multivariate analysis was performed to look for 
potential predictors of brain and ventricular volume; age, gender, syndrome, Chiari 
I malformation and vault expansion. If patients had more than one MRI, only the 
first was used in the analysis, and patients with a ventriculoperitoneal shunt were 
excluded from the analysis. Syndromes were put in the model as dummy variables. 
The intraclass correlation coefficient was calculated to compare the within-rater and 
betweenrater reliabilities of the volume measurements. All analyses were done with 
SPSS 16.0 for Windows. This study was approved by the medical ethical committee of 
the Erasmus University (MEC2005-273).
RESULTS
Between February 2004 and January 2011, 103 patients were invited to receive an 
MRI of whom 19 refused to participate. The 84 patient who received an MRI had a 
mean age of 8.1 years (range 0.3–18.3 years). Of the 84 patients, 13 had Apert syn-
drome, 31 Crouzon syndrome, 15 Muenke syndrome, 10 Saethre-Chotzen syndrome 
and 15 complex craniosynostosis. The total group consisted of 44 females and 40 
males. A vault expansion was performed in 66 patients prior to the MRI, at a mean age 
of 1.1 years. A Chiari I malformation was found in 12 (14%) patients, one (8%) patient 
with Apert syndrome, 10 (32%) with Crouzon syndrome and one (7%) with Muenke 
syndrome. Three patients had a ventriculoperitoneal shunt and were excluded from 
the ventricular volume analysis. All three had Crouzon syndrome. The mean brain vol-
umes at 1, 4, 8 and 12 years of patients with craniosynostosis and normal controls are 
shown in Table 1. There was no significant difference between patients and normal 
controls. Age had a significant influence on brain volume (p<0.001) but not on ven-
tricular volume. The brain volume increased significantly in the first 5 years (p=0.004) 
after which it stabilized. Patients with Apert syndrome (p=0.004) had a significantly 
larger ventricular volume compared to all other patients. Patients with a Chiari I mal-
formation (p<0.001) had a significantly larger ventricular volume compared to pa-
tients without a Chiari I malformation. Unexpectedly, Crouzon syndrome as such was 
not significantly associated with ventricular volume, although most patients (10 out 
of 12) with a Chiari I were diagnosed with Crouzon syndrome. Patients with Crouzon 
syndrome and a Chiari I malformation were significantly older compared to Crouzon 
patients without a Chiari I malformation, the mean age being 10.1 versus 8.0 years 
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(p=0.018). Furthermore, they had a larger ventricle volume (p=0.019) and were less 
likely to have had a vault expansion (p=0.049). The syndrome-specific relation be-
tween age and total ventricular and brain volume is shown in Figures 1 and 2.
Table 1 Mean brain volume of patients with syndromic craniosynostosis 
and of normal controls
Craniosynostosis Normal controls13-15 p-value
1 year
n 4 29
Age 0.90 (0.43) 1.06 (0.03) 0.048
Brain volume 924.25 (254.62) 855.54 (12.43) 0.118
4 years
n 8 26
Age 3.95 (0.60) 3.96 (0.52) 0.960
Brain volume 1280.88 (162.05) 1210.62 (109.20) 0.166
8 years
n 16 20
Age 8.41 (0.83) 8.60 (0.70) 0.461
Brain volume 1403.44 (156.87) 1391.42 (23.54) 0.883
12 years
n 16 20
Age 11.92 (0.60) 12.10 (0.60) 0.396
Brain volume 1464.50 (148.01) 1439.17 (23.54) 0.455
DISCUSSION
In this study we compared the total brain volume of patients with complex or syn-
dromic craniosynostosis to that of normal controls from the literature. Furthermore, 
we looked for predictors of brain and ventricular volume. We found that the total 
brain volume in patients with complex or syndromic craniosynostosis is similar to 
that in normal controls and that ventricular volume was significantly related to Apert 
syndrome and the presence of a Chiari I malformation. 
 The majority of patients with syndromic and complex craniosynostosis have 
a normal or even enlarged intracranial volume, before as well as after vault expan-
sion.9-12 The finding that brain volume is normal suggests that the compensatory skull 
growth is sufficient, to allow normal brain growth. The excess of cerebrospinal fluid 
we observed may be the driving force behind this compensatory growth of the skull. 
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Therefore, in these patients, raised ICP is more likely to result from raised CSF pres-
sure than from a mismatch between intracranial and brain volume. In most patients 
this raised CSF pressure will have a communicating character with papilledema as the 
only sign.16
 Chiari I malformation is primarily seen in patients with Crouzon syndrome. 
In our population 32% of the patients with Crouzon syndrome had a Chiari I malfor-
mation, compared to 73% perviously reported by Cinnali et al.17 This difference can 
perhaps be explained by the fact that they performed an MRI in case of clinical signs, 
while we performed MRI as part of a prospective study and in most cases without a 
clinical indication. 
 The diagnosis of Crouzon syndrome itself was not associated with an enlarged 
ventricular volume when it was corrected for Chiari I malformation. This means that 
Chiari I malformations have a stronger relation with ventricular volume than Crouzon 
syndrome by itself. With the lack of consecutive data, we are not able to tell whether 
Chiari I malformation precedes or follows the enlarged ventricular volume. Enlarged 
ventricular volume could be the consequence of reduced CSF outflow due to Chiari I
but could also be the cause of downward pressure on the cerebellum due to raised 
ICP. Chiari I malformations and raised ICP are both prevalent in Crouzon syndrome.18  
 In Apert syndrome larger ventricles are not related to Chiari I malformation, 
as only 2 to 8% of the patients with Apert syndrome have a Chiari I malformation.17 
Despite the larger ventricular volume, patients with Apert syndrome have a relatively 
low prevalence of increased ICP.19 This could be due to their significantly larger intra-
cranial volume before and after vault expansion.9-10 In Apert syndrome extra compen-
satory growth of the skull is facilitated by the enlarged anterior fontanelle that stays 
open for a relatively long period, preventing the development of increased ICP. 
Conclusion 
For the first time we show that patients with syndromic and complex craniosynostosis 
have a normal total brain volume. Therefore, it is unlikely that a mismatch between 
intracranial and brain volume is the main cause of raised ICP. Furthermore, we found 
enlarged ventricular volume to occur particularly in patients with Apert syndrome 
and patients with a Chiari I malformation. Patients with Crouzon syndrome are espe-
cially at risk for Chiari I, but those without a Chiari I have normal ventricular volumes. 
We advice screening of all patients with Apert and Crouzon syndrome for the devel-
opment of enlarged ventricle volume and the presence a Chiari I malformation.
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ABSTRACT
Background Patients with Apert and Crouzon syndrome, and craniofrontonasal 
dysplasia need a vault expansion within the first year of life to treat or prevent the 
development of raised intracranial pressure. Many craniofacial units perform a 
conventional posterior vault expansion as initial surgery, an alternative to this tech-
nique is the spring-assisted posterior vault expansion.
Objective To demonstrate the efficacy of spring-assisted posterior vault expansion 
and to compare this technique with the conventional method in children with mul-
tisuture craniosynostosis.
Methods A retrospective study was conducted among all consecutive patients who 
received a posterior vault expansion between 2006 and 2012. Patients treated with 
springs were compared with patients treated with the conventional technique for 
blood loss, duration of surgery, postoperative hospital admittance, increase in skull 
circumference and anterior-posterior length, and complications.
Results Of the 31 included patients, 15 were treated with springs and 16 with the 
conventional technique. Patients treated with springs had a significantly larger 
increase in skull circumference and anterior-posterior length, and less blood loss 
(difference not significant) compared with the conventional group. Complications 
in the conventional group were: minor dural tear in 3 patients, problematic wound 
healing in 1 patient, and insufficient expansion in 1 patient. Spring-related compli-
cations included skin perforation in 2 patients, a minor dural tear in 2 patients, and 
leakage of cerebrospinal fluid after an unnoticed dural tear during spring placement 
in 1 patient.
Conclusion Spring-assisted posterior vault expansion has many advantages over the 
conventional technique and is therefore the preferred technique in our center.
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INTRODUCTION
Patients with multisuture craniosynostosis need a vault expansion within the first 
year of life to treat or prevent the development of raised intracranial pressure (ICP). 
In many craniofacial units a posterior vault expansion is done as initial surgery in 
patients with Apert and Crouzon syndrome, and craniofrontonasal dysplasia. It is 
thought that posterior vault expansion offers a greater volume increase compared 
to frontal vault expansion, preserves the facial profile in case of midface hypoplasia, 
and leaves the frontal part of the skeleton untouched which may reduce the com-
plications of a monobloc or facial bipartition performed at a later age.1 The conven-
tional technique for posterior vault expansion needs a large dural dissection com-
pared to the spring technique to release the dura from the bone flap; this involves 
a higher risk for significant blood loss. Furthermore, the amount of push back of the 
occiput is restricted by the tightness of the skin. These problems have been solved 
with the introduction of distraction osteogenesis assisted vault expansion.2-5 The 
current technique with internal distractors that protrude through skin incisions has 
some disadvantages such as pin infection and mechanical problems.6 Spring-assisted 
posterior vault expansion is a possible alterative. Spring-assisted expansion was 
introduced by Lauritzen et al.7 and has since been used for various indications and 
types of craniosynostosis.8-10
The aim of this study was to demonstrate the efficacy of spring-assisted posterior 
vault expansion and to compare this technique with the conventional method in 
children with multisuture craniosynostosis.
PATIENTS AND METHODS
A retrospective study was done on all consecutive patients who received a poste-
rior vault expansion between February 2006 and December 2011. Demographic 
data of all patients were collected, including syndrome diagnosis, gender, and age 
at surgery. Perioperative data included estimated blood loss, duration of surgery, 
postoperative hospital admittance, gain in skull circumference (expressed in stan-
dard deviation; SD), gain in anterior-posterior (AP) length, maximal spring expan-
sion, presence of ossification defects, and the presence of papilledema. Standard 
deviations of skull circumference were used to correct for rapid skull growth during 
infancy. The SD was calculated with Growth Analyser 3.0. The AP length was mea-
sured by taking the longest distance from forehead to occiput on lateral skull X-rays. 
Gain in AP length was calculated from the difference between pre and post length. 
At the end of the expansion the excursion of the most cranial spring was measured, 
108
Chapter 8
as this spring reaches most excursion. The presence of ossification defects one year 
after expansion was studied on lateral skull X-rays. Complications occurring within 
the first 30 days after surgery were included. Data of patients who received the con-
ventional technique were compared with those who received spring-assisted vault 
expansion.
The spring technique was introduced in our center in 2009 and has been used since 
in almost all cases. According to our protocol, an occipital expansion is first choice 
for patients with Apert, Crouzon/Pfeiffer, craniofrontonasal dysplasia (CFND), or 
multisuture synostosis involving the lambdoid sutures. Because Crouzon and Pfeiffer 
syndrome often cannot be distinguished from each other, even from a genetic point 
of view,11 they were considered to be a homogenous group.
If the patient is referred early, this primary occipital vault expansion is planned 
around the age of 6 months. For patients who require a second skull expansion 
because of elevated ICP, an occipital expansion is chosen if the presenting shape of 
the skull allows it. If patients have severe obstructive sleep apnea or severe exorbit-
ism, we choose to perform a monobloc with distraction primarily. Another contra-
indication for posterior vault expansion is occipital anomalous venous drainage.12-13 
Division of these veins can lead to severe blood loss and a rise in ICP as the venous 
outflow is restricted.13
Statistical analysis
Differences between groups were compared with the Mann-Whitney U test. Differ-
ences in gain of AP length of the skull were analyzed with a linear regression model 
to correct for age at time of vault expansion. Percentage of blood loss was calculat-
ed by dividing the estimated blood loss by the circulating blood volume. Circulating 
blood volume was calculated using the formula 84 cc/kg for those aged 1-6 months, 
75.4 cc/kg for those aged 6-24 months, 75.7 cc/kg for those aged 2-5 years, and 
74.9 cc/kg for those aged 5-12 years.14 
Analyses were performed with SPSS 16.0 for Windows. A two-sided p-value of 0.05 
was considered to be significant.
Technical notes
Imaging through 3D CT-angiography is done before surgery to plan craniotomies and 
evaluate the presence of anomalous occipital venous collaterals.13 
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Spring technique
During surgery, patients are placed in prone position. After coronal incision and 
dissection, the occipital skin flap is pushed caudally. The neurosurgeon performs 
the osteotomy. For safety reasons, the most caudal horizontal osteotomy is posi-
tioned just above the transverse sinus and the torcula (Figure 1). In the center of 
the horizontal osteotomy a bone strip of 1 cm is left intact, to act as a hinge and 
prevent an inward collapse of the bone flap or the development of a large occipi-
tal ridge. If this bone strip is too thick to allow hinging, the outer cortex is drilled 
away. The bone flap is left attached to the dura at the site of the lambdoid sutures. 
In the youngest patients with thin bone in most cases four springs can be placed, 
whereas in the older patients six springs can be placed if considered necessary. The 
youngest child in whom we used springs was 5 months of age. Even when the bone 
was very thin or had several defects, a spot was always found to place the springs; 
no dural dissection was performed in these cases. Once the springs are inserted, 
the degree of widening of the osteotomy lines is judged (Figure 2). Particularly in 
secondary surgery the resistance can to be too strong to allow for adequate distrac-
tion. In those cases a limited detachment of the bone flap from the dura is created. 
We used 10.3 g springs (Active Spring Co. Ltd, UK), which produces a force of 3.11 
Nmm/degree. After surgery, all patients are transferred to the ICU and return to the 
ward the following day. Springs were left in place for an average of 76 days.  Springs 
were removed by opening the old scar. After removing the covering soft tissue, the 
springs were cut halfway which allows to take the springs out with a rotating move-
ment, given the curve at the end of the springs.
Conventional technique
For the conventional technique the same positioning of the patient, incision and os-
teotomy lines are used. An extra osteotomy line is added to create a bandeau of the 
most anterior part of the bone flap.  The bandeau is placed horizontally, just above 
the occipital osteotomy. The  bone flap is used to close the remaining defect, with 
the aim to gain as much volume as possible, with the tightness of the skin to allow 
closure being the limiting factor. The bandeau and the bone flap are fixed with re-
sorbable plates and screws. After surgery, all patients are transferred to the ICU and 
return to the ward the following day. Postoperative skull x-rays of both techniques 
are shown in .
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Figure 1 Osteotomy lines for the spring-assisted posterior vault expansion 
Arrow: right lambdoid suture.
Figure 2 Placement of six springs. The gap at the osteotomy line is the direct effect 
of the springs.
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Figure 3 Lateral skull x-ray after spring placement
Figure 4 Lateral skull x-ray after the conventional technique. The bone flap is fixed 
with resorbable plates and screws.
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RESULTS
In the defined period 31 patients received a posterior vault expansion, 15 with 
springs and 16 with the conventional technique. There were 7 males in the spring 
group and 8 in the conventional group. Diagnosis in the spring group included Apert 
(n=5), Crouzon (n=2), Saethre-Chotzen (n=2) and Kabuki syndrome (n=1), EFNB1-
craniofrontonasal dysplasia (n=3), and complex craniosynostosis (n=2). Diagnosis in 
the conventional group included Apert (n=3) and Crouzon syndrome (n=6), EFNB1-
craniofrontonasal dysplasia (n=1) and complex craniosynostosis (n=6). Posterior 
vault expansion was the first procedure in 9 patients treated with springs and in 13 
treated with the conventional technique. In both groups, the mean age at time of 
surgery in primary cases was 1.2 years. In secondary cases, it was 3.1 years in the 
conventional group and 3.8 years in the spring group.
 Perioperative data are presented in Table 1. There was no significant differ-
ence in blood loss, surgical time, or duration of postoperative hospital admittance 
between groups. Increase in the  SD of skull circumference was significantly larger in 
the spring group (p=0.029), as was the increase in AP length of the skull (p=0.028). 
The time interval between the AP measurement prior to and after surgery was 6.1 
months for the spring group and 8.5 for the conventional group (p=0.17).
 At the time of removal the springs positioned the most cranially, spread for 
an average of 41 (range 22-62) mm. Postoperative ossification defects were seen 
in 4 patients treated with a conventional expansion and in 3 patients treated with 
springs. The group with ossification defects had a mean age at expansion of 3.4 
years compared to 1.4 years in the group without defects (p=0.006). One patient 
treated with springs needed plate fixation after removal of the springs, because 
there was insufficient ossification for stability. Papilledema was present prior to 
posterior vault expansion in 7 (47%) patients of the spring group and in 7 (44%) of 
the conventional group; this resolved in all cases treated with springs. In the con-
ventional group papilledema persisted in one patient and one patient developed 
papilledema two years after vault expansion.
 Spring-related complications included skin perforation in 2 patients, a minor 
dural tear in 2 patients, and an unnoticed dural tear during spring placement in 1 
patient. As the springs expanded the leakage of cerebrospinal fluid became no-
ticeable, after which the springs were removed earlier than scheduled and a con-
ventional expansion was performed. In 1 patient a spring perforated the skin and 
needed to be removed, while the other three springs were left in place; this was a 
complicated case as he was already operated on twice in another center and in both 
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instances an extensive number of metal plates and screws were used. However, 
this complication did not affect the obtained expansion of his skull. Complications 
seen in the conventional group included a minor dural tear in 3 patients, problem-
atic wound healing in 1 patient, and insufficient expansion in 1 patient. The patient 
with insufficient expansion received a spring-assisted posterior vault expansion 20 
months after the conventional occipital expansion due to persisting papilledema.
Table 1 Data on perioperative posterior vault expansions
Conventional
n=16
Springs
n=15
Placement Removal
Mean age at surgery, 
years
1.6 2.2 2.4
Blood loss, % 44 29 13
Duration of surgery, 
minutes
164 142 59
postoperative admit-
tance, days
4.1 3.6 1.2
Increase in skull cir-
cumference, sd
0.9 - 1.9
Increase in anterior-
posterior length, cm
1.7 - 2.3
DISCUSSION
Compared to the conventional technique, spring-assisted posterior vault expan-
sions are associated with a larger increase in skull circumference and AP length. 
Blood loss was lower in the spring compared with the conventional group, but the 
difference was not significant. Most complications seen in both groups were minor. 
In the spring group 1 patient needed additional surgery for removal of one of the 
four springs after skin perforation, and springs had to be removed early in 1 patient 
when cerebrospinal fluid leakage was noticed during expansion. In patients treated 
with the conventional technique this dural tear would probably have been noticed 
during surgery, whereas with springs the bone flap is left in place and may hide 
dural tears. Therefore, in patients treated with springs, meticulous inspection of the 
dura is indicated before closure to prevent traction on the dura tear.
114
Chapter 8
Although there was no significant difference in blood loss between the groups, we 
consider the conventional technique to involve a higher risk of significant blood loss. 
The reason that we did not find this difference is probably due to our preference to 
put the lowest osteotomy just above the transverse sinus, to minimize the risks for 
blood loss. 
 Patients with Apert, Crouzon, CFND and multisuture craniosynosis are at risk 
of developing several episodes of raised ICP  and most patients need a midface ad-
vancement or facial bipartition to treat midface hypoplasia and/or hypertelorism.15 
A primary posterior vault expansion will give a large increase in intracranial volume 
while leaving the anterior skull untouched. This enables us to perform the midface 
advancement or facial bipartition at a later age, with a reduced risk of complications 
from difficult dissection in a previously operated area. 
 To treat raised ICP in craniosynostosis a vault expansion is the primary choice 
of treatment in most instances. Depending on the cause, treatment of OSA and 
hydrocephalus must also be considered when present.  During vault expansion the 
intracranial volume increases, correcting the cranio-cerebral disproportion. This 
might be present even in patients with an enlarged intracranial volume due to en-
larged ventricular volume.16 Because springs result in a significantly larger increase 
of skull circumference and AP length, we assume that springs are associated with a 
larger increase in intracranial volume. In turn, a larger increase in intracranial vol-
ume will most likely be more effective in treating elevated ICP and preventing future 
episodes. 
 The AP measurement was not expressed in standard deviations and the 
increase we found in AP length will be partially attributed to the growth during 
the measurement interval. However, the spring group had a shorter measurement 
interval (6.1 versus 8.5 months) with a larger increase of AP length, and therefore 
we may conclude that with springs a larger expansion is achieved compared to the 
conventional technique. A similar magnitude of expansion can be obtained through 
distraction osteogenesis with internal distractors.4 Both devices have the same 
disadvantage, that they have to be removed in a second procedure. Patients with 
internal distractors also need capable and involved parents to daily turn the screws. 
Furthermore, internal distractors are associated with complications such as break-
age, loosening of the footplate, and trauma to the distractor4, 17 and need solid bone 
for screw fixation. Our experience with internal distractors is limited to 1 case who 
developed long-lasting wound-healing problems during and after distraction. An 
advantage of internal distractors is that they allow a more gradual distraction of 
0.5-1 mm a day, resulting in an osteogenetic effect. Springs give the largest distrac-
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tion force in the beginning, after which the force decreases with expansion of the 
springs. Theoretically, this may cause incomplete ossification, although a higher age 
appeared to be a more important factor for an ossification defect. At the young age 
when most patients require an occipital expansions the ossification rate is so high 
that the true advantage of gradual distraction is not of major importance. In our 
experience internal distractors should be reserved for older patients who are more 
depended on distraction osteogenesis to allow bone formation, who are more com-
pliant in dealing with an external device and in whom bone thickness allows fixation 
of a distractor. In the future, additional adjustments of the springs will be made on 
an individualized custom-made basis, and possibly made of resorbable material to 
preclude the second procedure.18
Conclusion
This study compared the efficacy of spring-assisted posterior vault expansion with a 
conventional method in children with multisuture craniosynostosis. Spring-assisted 
posterior vault expansion is associated with a larger increase in skull circumference 
and AP length of the skull. Springs can applied in the very young, making springs a 
useful alternative for vault expansions performed with the conventional technique 
or with internal distractors.
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Chapter 9
 DISCUSSION
This thesis addresses several outcomes of care for patients with syndromic and 
complex craniosynostosis.  In this chapter first the main findings of this thesis will be 
discussed followed by the interpretation of the results, clinical implications and rec-
ommendations for future research.  The main strength of this thesis is the relatively 
large cohort available in the Dutch craniofacial center, Rotterdam.
MAIN FINDINGS
- With our treatment protocol the lifetime prevalence of raised intracranial   
 pressure (ICP) is 53% in Crouzon, 33% in Apert, 21% in Saethre-Chotzen and  
 5% in Muenke syndrome, despite routine early vault expansion. The onset of  
 raised ICP is in almost all cases before the age of 6 year.
- The main cause of hearing loss in Muenke syndrome is sensorineural hearing  
 loss that is particularly larger at the lower frequencies. This type of 
 sensorineural hearing loss is not seen in other craniosynostosis syndromes.
- Patients with syndromic craniosynostosis have a normal total brain volume  
 compared to normal controls. 
- The main reported causes of a lower quality of life include: problems with  
 vision, hearing and speech in all syndromes, with cognition in Apert, Crouzon  
 and Muenke syndrome and with dexterity in Apert syndrome.  
- The Health Utility Index (HUI)-3 has a medium to strong correlation with   
 objective measurements of vision, hearing and intelligence. However, in 
 individual patients there can be a big discrepancy between the objective   
 measurement of vision, hearing and intelligence and that reported by the 
 parents.
- Patients with Apert syndrome can achieve a good quality of life and low   
 activity limitation regarding upper and lower extremity. However, quality of  
 life and activity limitation have a broad range about one third of the patients  
 will obtain a very low quality of life and/or high activity limitation.
- Muenke syndrome can be associated with hypoplasia of the frontal sinus,   
 dysplastic elbow joints with restricted elbow motion, mild cutaneous 
 syndactyly and ptosis of the upper eyelids. Particularly this last finding  
 makes  a clinical distinction from Saethre-Chotzen syndrome difficult and   
 therefore genetic analysis is required.
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- Good long-term intelligence and visual acuity can be achieved with the   
 current treatment protocol of performing a vault expansion prior to the age  
 of 1. However, a significant larger proportion of patients in all syndromes 
 has an IQ lower than -2sd compared to the normal population (46% Apert,  
 16% Crouzon, 12% Saethre-Chotzen, 2.3% norm). 
- Spring assisted posterior vault expansion results in a larger increase in skull  
 circumference and anterior-posterior length compared to the conventional  
 technique and is thus associated with a larger increase in intracranial 
 volume.
INTERPRETATION OF RESULTS
Intracranial pressure
Close follow-up for the development of raised ICP is indicated in syndromic cranio-
synostosis because it is related to vision loss and thought to negatively influence 
intelligence on the long-term.1-4 In chapter 2 we report on the lifetime prevalence of 
raised ICP. In our center the diagnosis of raised ICP is primarily based on presence of 
papilledema at fundoscopy. The interpretation of a fundoscopy is observer-depen-
dent and the sensitivity is reported to be low (22%)  in patients under the age of 8 
years.5 However, this is the only publication on the sensitivity and specificity of pap-
illedema in young children. More research on this topic is indicated, as fundoscopy 
is a frequently used screening method for raised ICP. The low sensitivity of fundos-
copy suggests that the prevalence we found could be an underestimation. We found 
raised ICP in 53% of the patients with Crouzon, 33% with Apert, 21% with Saethre-
Chotzen and in 5% with Muenke syndrome. A previous study from Paris reports 
frequencies of raised ICP of 62.5% in Crouzon syndrome, 45% in Apert syndrome, 
and 29% in the other syndromes based on intracranial measurements.6 If we com-
pare our prevalence of papilledema to the reported frequency of raised ICP based 
on intracranial measurements by Paris, we may conclude that we theoretically miss 
approximately 10% of the patients with raised ICP. This indicates that the sensitivity 
of fundoscopy  in our unit is higher than the previous reported 22% in patients un-
der the age of 8 years.5 This higher sensitivity is probably due to the fact that all our 
patients are screened by a small group of experienced pediatric ophthalmologists. 
The sensitivity will however never be 100%. Therefore the chance for false-negative 
results remains. On the other hand, when compared to the gold standerd intracrani-
al pressure measurements, fundoscopy is non-invasive, can frequently be repeated, 
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does not need 24 hours admittance to the hospital, is inexpensive and is not associ-
ated with severe complications such as haemorrhage and infection. 
 To prevent missing the diagnosis of raised ICP additional screening methods 
should be considered. Potential useful methods are ultrasonographic measure-
ments of the diameter of the optic nerve sheet (ONS),7 visual evoked potentials 
(VEP’s)8 and optical coherence tomography (OCT) of the optic disc.9 Ultrasonography 
of the ONS diameter gives a real time indication of the ICP,7 because at daytime ICP 
is normal in most cases the measured ONS ultrasonography is negative.10 However, 
during nocturnal episodes of raised ICP the diameter of the ONS increases making 
ultrasonography of the ONS only useful when measurements can be performed 
during sleep, preferably during REM sleep when ICP peaks. An advantage of  ultraso-
nography of the ONS is that there is no need for patient cooperation since measure-
ments are taken during sleep. This makes this method useful for all ages.
 Optical coherence tomography is able to reveal a higher number of optic ab-
normalities compared to fundoscopy in patients with idiopathic intracranial hyper-
tension.9 It is a quick procedure making it potentially useful as a screening method 
for patients with craniosynostosis, especially as it provides quantitative data. A 
downside of this method is the need for patients to cooperate. This will be difficult 
in at least some of the patients, especially the younger ones who are most at risk of 
developing raised ICP. In our experience OCT gives reliable results in most children 
from the age of 3 years. Furthermore, results of OCT in patients with craniosynosto-
sis or healthy children are not yet available and comparison to intracranial pressure 
measurements are missing in the current literature. 
 In the craniofacial unit at Great Ormond street (London) VEP’s are used to 
detect raised ICP.8, 11-12 Serial recordings are required to diagnose central vision dys-
function, because the VEP’s can initially be within the normal clinical range. Gradual 
loss in amplitudes of the VEP are used to recognize the presence of raised ICP. This 
technique can be used in all ages, but is influenced by cooperation and arousal of 
the patient.13 A disadvantage of this technique is the need for frequent and time 
consuming recordings which is a burden to both the patient and parents and to the 
ophthalmologic department. Although the sensitivity of serial VEP may be higher 
than fundoscopy, still cases with raised ICP can be missed due to false-negative re-
sults.
 Invasive intracranial pressure measurements should be considered when 
there is a high clinical suspicion (decline in growth of the skull circumference, cop-
per beaten pattern) for raised ICP in the absence of papilledema, in the decision 
making for a second vault expansion in the presence of intermitting or a trace of 
125
General discussion
papilledema and whenever papilledema does not disappear within 3 to 6 months 
after vault expansion. 
 Patients with syndromic craniosynostosis often develop a second episode of 
raised ICP, whether they have received a routine skull expansion within their first 
year of life (Paris and Rotterdam protocol) or only at presentation of signs of el-
evated ICP (London protocol). The cumulative incidence of this episode is highest in 
Crouzon syndrome and is seen around the age of 3 years. The cause of this episode 
remains unknown at this moment but must be related to a mismatch between 
intracranial volume relatively to the intracranial volume of brain, cerebrospinal fluid 
(CSF), and blood.  
 Most patients with Apert and Crouzon syndrome do have a larger intracra-
nial volume compared to normal controls, prior and post vault expansion. In most 
cases this can be explained by the enlarged ventricle volume seen in patients with 
Apert syndrome and Crouzon syndrome with Chiari I malformation There are how-
ever some patients that have a smaller or near normal intracranial volume; particu-
larly patients with Crouzon syndrome can develop pansynostosis during their first 
years of life, resulting in a deviation of the skull circumference curve. These patients 
might be the ones who are particularly at risk of developing a second episode of 
raised ICP. This hypothesis is supported by the results of Renier et al. who found 
that a smaller intracranial volume is related to a higher risk of developing raised 
ICP15 and the fact that brain volumes are comparable to that of normal controls 
(chapter 7). Testing the hypothesis that a relatively too small intracranial volume 
is the cause of the second episode of raised ICP requires a longitudinal study with 
repeated measurements of the various components of intracranial volume and oc-
currence of raised ICP. 
 Other potential causes are an increase of CSF and/or blood volume. Al-
though we did not find an increase of ventricular volume with age in chapter 7, 
this was a cross-sectional study and longitudinal results have to confirm our data. 
Ventricular volume increase could be related to restricted outflow or limited absorp-
tion of CSF. Whether ventricular volume increases and if this is related to restricted 
outflow should be studied with serial MRI studies, including a phase-contrast serie 
which can show CSF flow and the level op obstruction.18 Obstruction of outflow 
could be caused by a narrow foramen magnum and/or herniation of the cerebral 
tonsils.16-17 In case of a too small foramen magnum or a Chiari I malformation CSF 
flow is expected to be obstructed at the craniovertebral junction.18-19 Another 
potential side of obstruction is the cerebral aquaduct. However, obstruction of CSF 
is not the only cause of enlarged ventricular volume as third ventriculostomy does 
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not treat this in all cases.20 Other causes of an enlarged ventricular volume could 
be overproduction of CSF or an abnormal development of the ventricles. Raised ICP 
could also be caused by an increase of intracranial blood volume that could poten-
tially be caused by nightly obstructive sleep apnea (OSA) or by a too small jugular 
foramen.10, 21-22 Intermitting episodes of OSA cause hypercapnia, hypoxemia and a 
negative intrathoracic pressure. Hypercapnia causes an intracerebral vasodilata-
tion, while hypoxemia and a negative intrathoracic pressure result in pulmonary 
hypertension wich obstructs the intracranial venous outflow. These mechanisms 
could cause an increase in intracranial blood volume leading to episodes of raised 
ICP. Furthermore, the obstructive  moment will end with a moment of arousel which 
increases the heart rate, blood pressure and cardiac output, this could also cause 
a raise in ICP. Obstructive sleep apnea is found in around 30% of the patients with 
Crouzon and Apert syndrome in a retrospective study (chapter 2).  From prospective 
data we now know that the prevalence is much higher, around 68% (Driessen et al. 
Unpublished data) and that severity of obstructive sleep apnea in syndromic cra-
niosynostosis decreases or stabilizes with age and does not peak around the age of 
3 years.23 It is therefore unlikely that OSA is the main cause for the second episode 
of raised ICP since this episode is usually seen around the age of 3 years. A small 
jugular foramen could cause a raise in ICP by obstructing venous outflow resulting 
in an increase of intracranial blood volume. However, the relation between a small 
jugular foramen and raised ICP as reported by Rich et al.22 could not be reproduced 
in our population (Florisson et al. personal communication). This makes a too small 
jugular foramen an less likely cause for raised ICP in patients with syndromic cranio-
synostosis. 
 To determine whether insufficient intracranial volume and/or an increasing 
ventricular volume are related to the second episode of raised ICP, a longitudinal 
study is indicated. This study should include a CT-scan pre and post vault expan-
sion to measure intracranial  volume and routine MRI with a phase-contrast serie to 
study CSF flow and brain and ventricular volume.
Quality of life
There are many potentially functional and psychological problems that can influence 
the quality of life of patients with syndromic craniosynostosis and their parents. 
However there is only one previous publications on this topic.24 To address this im-
portant topic we used different questionnaires to asses quality of life in this thesis. 
In chapter 5 we studied health related quality of life of patients with syndromic and 
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complex craniosynostosis based on the HUI-3. In chapter 6 we used several ques-
tionnaires to assess quality of life and disability of the upper and lower extremity in 
patients with Apert syndrome.
 The only previous reported study on quality of life in patients with syndromic 
craniosynostosis was also performed in Rotterdam and includes partially the same 
patients.24 Bannink et al. reported a lower quality of life compared to that of normal 
controls. Furthermore, they found a significantly lower quality of life of the parents 
on psychosocial domains of the Short Form (SF)-36.
 The main causes of a lower quality of life that we found included problems 
with vision, hearing and speech in all syndromes, cognition in Apert, Crouzon and 
Muenke syndrome and dexterity in Apert syndrome. Vision will get sufficient at-
tention during follow-up in most patients because they are routinely referred to a 
paediatric ophthalmologist for fundoscopy.25 The need for regular visits to a paedi-
atric ophthalmologist should be emphasized to all parents, to diagnose raised ICP 
and strabismus.26 Especially raised ICP can have a devastating effect on the vision 
of both eyes when left untreated.1, 27 Hearing and speech may get less attention. 
Based on our results we advice screening for hearing loss early in life in all patients. 
In patients with Muenke syndrome SNHL is the main cause of hearing loss there-
fore screening should especially be focused on this type of hearing loss. Regular 
follow-up for recurrent otitis media and conductive hearing loss should be done for 
patients with Apert and Crouzon syndrome (chapter 4). In chapter 5 speech was 
one of the main problems reported by parents. However, literature on this topic is 
limited. One study on Apert syndrome reports factors for speech problems including 
oral abnormalities, recurrent episodes of hearing loss (due to middle ear infections) 
and a lower cognition.28 Non-syndromic craniosynostosis is also associated with 
speech and language  abnormalities in 23-37% of the cases.29-30 Reported risk factors 
for speech abnormalities in non-syndromic craniosynostosis are synostosis of the 
coronal sutures, lower cognition and family history of speech and language impair-
ment.29-30 Recurrent episodes of hearing loss were not found to be related to speech 
and language impairment.30 However, from larger studies on patients with cleft lip 
and palate we know that hearing loss is associated with speech and language im-
pairments.31-32 From these results we might deduce that to improve speech we have 
to treat oral abnormalities and hearing loss, and screening for speech abnormalities 
by a speech therapist should at least be done in patients with oral abnormalities, 
recurrent episodes of hearing loss, a lower cognition and a family history of speech 
and language impairment.
 In patients with Apert syndrome quality of life is negatively associated with 
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activity limitation, predicting 20-55% of the experienced quality of life (chapter 6). 
In the other forms of syndromic craniosynostosis none or only minor abnormalities 
of the extremities are found33-36 and will therefore only have a small influence on 
quality of life. 
 Besides health related problems there are several psychological factors 
related to quality of life in with congenital facial disfigurements. Known psycho-
logical problems in patients with congenital disfigurements are low satisfaction 
with appearance, fear of negative appearance evaluation and low self-esteem.37-38 
These problems could also be present in patients with syndromic craniosynostosis. 
A known period with high psychological stress is the period around craniofacial 
surgery. This period will have a large impact on patients and their parent. Patients 
experience stress mainly due to change in facial appearance, ICU stay, feeding dif-
ficulties and removal of external distractors (Bredero et al. submitted). Parents can 
experience stress because they have to make a decision for their child whether to 
be operated or not, change in appearance and feeding problems (Bredero et al. 
submitted). Therefore we advice to inform all parents about psychosocial problems, 
especially around the period of craniofacial surgery and offer them psychological 
support whenever needed. Future research should focus on how to prepare families 
for craniofacial surgery in such a way that stress is reduced. Furthermore, change 
in satisfaction with appearance before and after craniofacial surgery and its influ-
ence on social functioning should be prospectively tested. This information will help 
in guiding the parents and patients in making the decision to undergo craniofacial 
surgery.
 A limitation of our study is the use of proxy reports. This was done because 
of the high prevalence of cognitive impairment, especially in Apert and Muenke 
syndrome (chapter 8). On an individual level parental proxy reports may give a 
distorted view. Ardon et al. found that despite the fact that mean outcomes do not 
differ significantly, on an individual level large disagreement can be found between 
patients and parents, that can go in both directions.39 Child’s pain and parental well 
being are reported to influence parental proxy reporting.40 Researchers should be 
aware of these confounders whenever children are unable to complete quality of 
life questionnaire themselves.
 For clinical evaluation standardized outcome measures should be used to 
make comparison between different centers easier.41-43 Preferably these outcomes 
are objectively measured and can be quantified to aid in comparison between dif-
ferent treatment options and protocols. A suggestion for standardized outcome 
measures are given in Table 1. 
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Table 1 Suggestions for standardized outcome measures to use in clinical evaluation
parameter method
Functional ICP Screening: Fundoscopy (at routine visits),  growth 
chart of skull circumference (at routine visits),
Diagnosis: intracranial measurement (when in 
doubt), MRI (excluding hydrocephalus)
Obstructive slee apnea
Sleeping
Screening: Brouilette score (OSA-18)
Diagnosis: PSG (first visit/pos. Brouilette)
Nocturnal  EEG (clinical complaints)
Vision
Function of lacrimal 
apparatus
Visual acuity (at routine visits), 
Eye examination by ophthalmologist (clinical com-
plaints)
Hearing Audiometry (early in life all/ clinical suspicion)
Oral health (problems 
with teeth, occlusion)
Speech intelligibility
Oral examination by dentist (after start primary 
dentition at routine visits)
Screening: MOS (screening)
Diagnosis: evaluation by speech therapist
nutritional status, growth Growth chart of wheight, length and skull circum-
ference (at routine visits), Weight (weekly during 
distraction)
Disability of the 
extremities
DASH, LEFS (at routine visits in Apert and Crouzon/ 
Pfeiffer)
Aesthetic Objective measurement Versnel score (clinical evaluation)
Satisfaction with (facial) 
appearance
VAS, Body Cathexis Scale (clinical evaluation)
Psychosocial Cognition Bayley scales of infant development (<6y, pre and 
post vault expansion), WISC (at least once >6y)
Behavioural problems
Psychosocial functioning
CBCL, SDQ (clinical complaints)
CHQ, SF-36 (clinical evaluation)
Quality of life Overall quality of life CHQ (patients <18 y), SF-36 (patients ≥18 y and 
parents) (clinical evalution)
MRI: magnetic resonance imaging, OSA-18: OSA disease-specific questionnaire, PSG: Polysomnogra-
phy, EEG: Electroencephalography, MOS: Mean Opinion Scale DASH: Disability of Arm Shoulder and 
Hand, LEFS: Lower Extremity Functioning Scale, VAS: Visual Analogue Scale, YQOL-FD: Youth Quality 
Of Life – Facial Differences.  WISC: Wechsler Intelligence Scale for Children, CBCL: Child Behaviour 
Checklist, SDQ: Strengths and Difficulties Questionnaires, CHQ: Child Health Questionnaire, HUI: 
Health Utility Index, SF-36: Short Form-36
130
Chapter 9
Surgical treatment
There are many surgical treatment options and protocols for patients with cranio-
synostosis. However, long-term functional outcomes are missing in the literature. 
The aim of chapter 7 was to report on long-term intellectual and visual outcome 
of patients treated according to the treatment protocol of the craniofacial units 
in Paris and Rotterdam. Most patients treated with this protocol achieved good 
long-term intelligence and visual acuity. However, a significant larger proportion in 
all syndromes has an IQ lower than -2sd compared to the normal population. The 
average IQ of patient who could be tested was 75 in Apert, 98 in Crouzon, 102 in 
Saethre-Chotzen, 77 in Muenke syndrome and 95 in complex craniosynostosis. The 
average visual acuity was 0.80 in Apert, 0.82 in Crouzon, 0.93 in Saethre-Chotzen, 
0.94 in Muenke syndrome and 0.98 in complex craniosynostosis (chapter 7 & un-
published data). This is in accordance with what parents reported in chapter 5.
 Only a small number of papers studied intelligence in syndromic craniosyn-
ostosis.44-50 In patients with Apert and Crouzon syndrome similar IQ’s were found.44, 
48-49 Higher IQ’s were reported in patients with Muenke syndrome and plagiocepha-
ly,50 no studies were found reporting on average IQ’s in Saethre-Chotzen syndrome. 
However, in patients with Saethre-Chotzen syndrome development delay is report-
ed in approximately 10% and higher frequencies of development delay are reported 
in patients with TWIST deletions.51-52  Based on the literature and our results we may 
conclude that syndrome diagnosis is the main predictor of IQ. It remains the ques-
tion if age at time of vault expansion influences long-term intellectual outcome. 
Studies on this topic present contradictory results; some state that surgery should 
be performed before the age of one year to get the best possible intelligence,6, 44 
while others can not find such a relation.45, 48-49
 Visual impairment, defined as a visual acuity of ≤0.5 in the best corrected 
eye, was found in 8% of the patients with Apert, Crouzon and Saethre-Chotzen 
(chapter 7). This is lower compared to the literature were visual impairment is re-
ported in 17%-35% of the patients with these syndromes.53-56 This difference might 
be explained by the close follow-up we perform in our craniofacial unit in the first 6 
years in combination with ophthalmological examinations. The main reported rea-
sons for visual loss are ametropia and amblyopia. Risk factors for amblyopia seen in 
syndromic craniosynostosis are strabismus, ametropia, astigmatism and ptosis. Op-
tic nerve atrophy, also thought to be a cause of vision loss in syndromic craniosynos-
tosis, is reported in 5%-16% of the patients with Apert and Crouzon syndrome54, 56-57 
and in 0%-10% of the patients with Saethre-Chotzen and Muenke syndrome.33, 58 We 
found a similar frequency of optic nerve atrophy in chapter 7. All the previous stud-
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ies on visual outcome show that vision loss in syndromic craniosynostosis is multi-
factorial. Therefore vision loss is probably more dependent on the ophthalmological 
follow-up and treatment than on timing of vault expansion. The long-term results 
of different treatment protocols are needed to allow comparison and aid in the 
discussion of timing of vault expansion. If similar long-term results can be achieved 
with the London protocol, the current dogma to perform vault expansion before the 
age of 1 year should be reconsidered. As long as this has not been demonstrated, it 
seems sensible to adhere to the current Rotterdam/Paris protocol.
 During the last 15 years an increasing number of craniofacial units are us-
ing posterior vault expansions as primary surgery in syndromic craniosynostosis 
with midface hypoplasia.59-62 The main advantage of a posterior vault expansion is 
the larger increase in intracranial volume compared to a frontal-orbital advance-
ment.63-64 Furthermore, it leaves the face untouched, making it easier to perform 
a monobloc or facial bipartition at a later age.  The gain in volume can be further 
increased by the use of springs (chapter 8). However, posterior vault expansions can 
be associated with severe complications when anomalous occipital venous drainage 
is present.65 A large part of the venous drainage can be cut during dissection result-
ing in an untreatable rise of intracranial pressure.66  
 Future research should focus on the development of raised ICP and Chiari I 
malformations after a posterior vault expansion. If a limitation in growth of intracra-
nial volume is a cause of the second episode of raised ICP, patients who received a 
primary posterior vault expansions might have a lower incidence of raised ICP. Fur-
thermore, the development of Chiari I malformations might be prevented or treated 
by the increased volume of the posterior fossa.67 When posterior vault expansions 
can prevent or limit the development of raised ICP and/or Chiari I malformations in 
at least some of the patients, it will justify the use of this method as primary sur-
gery. The additional value of distractors and springs should also be proven, to justify 
the use of these devices as they need a second surgery for removal. 
CLINICAL IMPLICATIONS
- Screening for raised ICP should be done pre- and post-surgery in all patients.  
 Thereafter it should at least be done annually until the age of 6 years in    
 Apert, Crouzon, Saethre-Chotzen and Muenke syndrome. Fundoscopy is at  
 this moment the preferred screening method.
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- Screening for hearing loss should be done early in life in all  patients with   
 syndromic craniosynostosis. In patients with Muenke syndrome screening
  should especially be focused on sensorineural hearing loss . Regular follow- 
 up for recurrent otitis media and conductive hearing loss should be done for  
 patients with Apert and Crouzon syndrome.
- Speech should be checked by a speech therapist in all children with oral  
 abnormalities, recurrent episodes of hearing loss, a family history of speech  
 and language impairment and a lower cognition. In patients with a very low  
 intelligence this might not be feasible.
- All parents should be informed about psychosocial problems that they and  
 their child can expect, especially around the period of craniofacial surgery of  
 their child.  Psychological support should be offered whenever needed.
- Screening for enlarged ventricular volume and the presence of a Chiari I mal 
 formation with the help of MRI is indicated in all patients with Apert and
 Crouzon syndrome at first presentation, at the age of 3-4 years and when   
 signs of raised ICP are present.
- Until long-term results of other treatment protocols are presented the 
 current protocol which implies vault expansion before the age of one and   
 close follow-up should be followed.
- Spring assisted posterior vault expansion is a useful technique to get a larger  
 gain in intracranial volume compared to the conventional technique. 
FUTURE PERSPECTIVES
- A high percentage of patients with syndromic craniosynostosis develop a   
 second episode of raised ICP around the age of 3 years. Understanding the 
 origin of this episode will guide future treatment and may prevent this 
 episode. Especially patients with Crouzon syndrome should be considered  
 for such a longitudinal study, as they have the  highest prevalence of raised  
 ICP.
- Several non-invasive methods are currently available to screen for raised ICP  
 including fundoscopy, OCT, VEP and ONS ultrasonography. At this moment  
 there are no or only limited data on the sensitivity and specificity of these  
 methods. These data are necessary to select the best method and help with  
 interpreting the test results.
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- Most studies on hearing loss are cross-sectional. Therefore knowledge about  
 how hearing loss evolves over time is missing. Especially in patients with  
 Muenke syndrome, who can have severe SNHL, this information is crucial  
 for patient follow-up and counselling. If the hearing loss does not worsen  
 over time a single screening for SNHL at an early age will be enough in   
 Muenke syndrome.
- Furthermore, results of brainstem evoked response audiometry and 
 auditory event related potential will give information about central sound  
 processing. This might give a better understanding of the brain functioning in  
 the very young patients.
- Studying the relation between elevated ICP, Chiari I malformation and 
 enlarged ventricle volume to determine which finding precedes the other. 
- Since 2006 several questionnaires have been used in our population.24, 37-38,  
 68-70 The next step would be to select the questions and questionnaires that  
 are best at measuring health status and change in health status change.  
 From the most informative questions a new questionnaire could be 
 developed specifically for craniosynostosis that covers all affected domains.  
 After validation this questionnaire should be used in all future research to  
 enhance comparability between different studies.
- Abnormal speech was found to have a large impact on quality of life. 
 However, at this moment information about the main problems causing  
 abnormal speech are missing. This knowledge is needed for adequate  
 screening and treatment. To improve our understanding of speech problems  
 in this population all parents and patients should be asked about speech   
 problems and referred to a speech therapist when present. The speech  
 therapist should report on the cause and the effect of treatment when given.
- Although a relatively large proportion of patients with Apert syndrome 
 are disabled due to problems with hips and knees, there are no studies,   
 except ours, on functioning of the lower extremity in Apert syndrome. More  
 knowledge about pathology and functioning of hips, knees and feet would  
 enable better screening and treatment improving quality of life. 
- To get international consensus on which treatment protocol results in the  
 best intellectual and functional outcome a RCT is probably needed. As this 
 study design is not very feasible, at least long-term data on intelligence 
 and visual acuity are needed from other treatment protocols. Given the   
 rarity of syndromic craniosynostosis, multi-center studies and international  
 cooperation will have a large added value.
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- Long-term results need to prove the usefulness of springs in preventing and  
 treating a second episode of raised ICP and Chiari I malformations.
-  The largest disadvantage of spring assisted posterior vault expansion is the  
 need for a second procedure to remove the devices. Resorbable springs with  
 the same mechanical property would prevent the need for a second surgery. 
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SUMMARY
The aim of this thesis was to give a better understanding of syndromic craniosyn-
ostosis regarding ICP, OSA, hearing loss and quality of life, describe the relation 
between genotype and phenotype, and report different outcomes of various treat-
ment options.
 Chapter 1: Craniosynostosis is a condition in which one or more sutures of 
the skull prematurely fuse. When craniosynostosis is associated with other congeni-
tal malformations and/or is caused by a mutation or deletion we speak of syndromic 
craniosynostosis. The most prevalent syndromes are Crouzon, Muenke, Saethre-
Chotzen and Apert. If no genetic cause can be found and two or more sutures are 
closed we speak of complex craniosynostosis. The aetiology, most prevalent prob-
lems, and the surgical treatment modalities are discussed in this chapter.
 Chapter 2 is a retrospective study describing functional problems of 167 
patients diagnosed with Apert, Crouzon, Pfeiffer, Muenke or Saethre-Chotzen syn-
drome, aged 1-25 years. The main results of chapter 2 and chapter 4 are presented 
in Table 1. The prevalence of raised ICP remains high in the first years after vault 
expansion, with a peak around the age of 3 years. Based on these data, guidelines 
for follow-up of patients per syndrome are suggested.
Table 1 main results of chapter 2 and 4
Raised ICP OSA* Refractive 
error
Strabismus Hearing loss
Apert 33% 31% 76% 93% 44%
Crouzon/Pfeiffer 53% 27% 39% 63% 29%
Muenke 5% 5% 49% 39% 29%
Saethre-Chotzen 21% 5% 52% 37% 62%
* Prospective numbers are higher due to the absence of routine PSG before 2006
The aim of chapter 3 was to report on long-term visual and intellectual outcome of 
the treatment protocol used in Rotterdam and Paris. We report on a group of 147 
patients with Apert, Crouzon and Saethre-Chotzen syndrome. All patients received 
early surgery and received an IQ test at the age of 6 years or older. Data of visual 
acuity was reported on in a subgroup of 39 patients from the Rotterdam cohort. 
There was a good long-term intellectual outcome in patients with Crouzon and Sae-
thre-Chotzen. Patients with Apert syndrome had a significantly lower IQ compared 
to both other syndromes (p<0.001). However, in all three syndromes a significantly 
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larger proportion had an IQ lower than -2 sd compared to the normal population 
(46% Apert, 16% Crouzon, 12% Saethre-Chotzen, 2.3% norm). On average, a good 
vision was found in all syndromes. Nevertheless, the visual acuity of the best cor-
rected eye was ≤ 0.5 in 8% of the patients. With our current policy to perform early 
vault expansions a good long-term intelligence and visual acuity could be achieved. 
However, despite early vault expansion a number of cases will still have a low IQ.
 Syndrome-specific type, severity, and prevalence of hearing loss is presented 
in chapter 4. Hearing loss is conductive in most patients with Apert, Crouzon, and 
Saethre-Chotzen syndromes and is predominantly sensorineural in patients with 
Muenke syndrome. Sensorineural hearing loss at lower frequencies is only seen in 
patients with Muenke syndrome. Based on these findings we recommend routine 
visits to the general practitioner or otolaryngologist, depending on national stan-
dards of care, to screen for otitis media with effusion throughout life. In addition, 
we recommend early screening for sensorineural hearing loss among children and 
young adults with these syndromes.
 Chapter 5 presents Health-related quality of life measured with proxy re-
ports of the Health Utility Index mark 3 (HUI-3) and the Visual Analogue Scale (VAS). 
All data were compared to a normative Dutch population. Vision, hearing and 
intelligence were objectively measured and correlated to the corresponding HUI-3 
attribute. The HUI-3 multi-attribute and the VAS were significant lower compared to 
the normative Dutch population. A high prevalence of vision and speech problems 
were reported in all syndrome groups. Cognitive problems were mainly reported 
in patients with Apert, Crouzon and Muenke syndrome. Ambulation and dexterity 
problems were reported in Apert, Crouzon, Saethre-Chotzen and complex cranio-
synostosis. Only patients with Apert syndrome scored significantly worse on pain. 
The HUI-3 attributes vision, hearing and intelligence had a medium to strong corre-
lation with the objectively measured visual acuity, hearing and intelligence.
 Chapter 6 describes quality of life and activity limitation of upper and lower 
extremity in patients with Apert syndrome aged ≥ 6 years. Questionnaires were 
answered by patients, patients with the help of a caregiver or by caregivers only. 
More than 60% of the patients with Apert syndrome have a quality of life and activ-
ity limitation within the normal limits. However, the outcomes of all questionnaires 
had a broad range and about one third of the patients obtained a very low quality of 
life and/or high activity limitation. Activity limitation was negatively correlated with 
quality of life. Caregivers scored significant higher on activity limitation compared 
to patients themselves. This difference was not found in the quality of life question-
naires. 
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In Chapter 7 we report on volumes of the total brain and ventricular system. Total 
brain volume in syndromic craniosynostosis equals that of normal controls, in the 
age range of 1 to 12 years. Brain growth occurred particularly in the first 5 years 
of age, after which it stabilized. Within the studied population, ventricular volume 
was significantly larger in Apert syndrome compared to all other syndromes and in 
patients with a Chiari I malformation. Chiari I malformations are mostly found in 
patients with Crouzon syndrome. Therefore we advice screening of all patients with 
Apert and Crouzon syndrome for the development of enlarged ventricle volume and 
the presence of a Chiari I malformation.
 In many craniofacial units a posterior vault expansion is done as initial sur-
gery in Apert and Crouzon syndrome, and craniofrontonasal dysplasia It is thought 
to offer a greater volume increase compared to frontal vault expansions and leaves 
the frontal part of the skeleton untouched which may reduce the complications of 
a monobloc or facial bipartition performed at a later age. Spring assisted posterior 
vault expansion could be a possible improvement for the conventional technique. In 
chapter 8 we report on spring assisted posterior vault expansion and compare this 
technique with the conventional technique in children with multisuture craniosyn-
ostosis. We included 31 patients, 15 treated with springs and 16 with the conven-
tional technique. Spring assisted posterior vault expansions were associated with a 
larger increase in skull circumference and anterior-posterior length. This with only 
minor complications. Blood loss and operation time were not significant different. 
We conclude that springs assisted posterior vault expansions are associated with a 
larger increase in intracranial volume and a useful alternative for conventional oc-
cipital expansion.
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NEDERLANDSE SAMENVATTING
Het doel van dit onderzoek was om een beter beeld te geven van syndromale 
craniosynostose ten aanzien van hersendruk, OSAS, gehoorverlies en kwaliteit van 
leven, om de relatie tussen genotype en fenotype te beschrijven en het presenteren 
van lange termijn resultaten van de chirurgische behandeling.
 Hoofdstuk 1: Craniosynostose is een aandoening waarbij één of meerdere 
schedelnaden prematuur sluiten. Als craniosynostose geassocieerd is met andere 
aangeboren afwijkingen en/of een genetische oorzaak heeft spreken we van syndro-
male craniosynostose. De meest voorkomende syndromen zijn Crouzon, Muenke, 
Saethre-Chotzen en Apert. Als er geen genetische oorzaak gevonden wordt en twee 
of meer schedelnaden zijn prematuur gesloten spreken we van complexe craniosyn-
ostose. Patiënten met craniosynostose hebben een schedel vergrotende operatie 
nodig om verhoogde hersendruk te voorkomen of behandelen. Dit wordt meestal 
voor het eerste levensjaar gedaan. Hiernaast kunnen ze een groot aantal andere 
klinische problemen hebben. Hierbij valt te denken aan slaap apneu syndroom, 
gehoor en visus daling, handafwijkingen en problemen met de ontwikkeling.
 Hoofdstuk 2 is een retrospectieve studie die de functionele problemen van 
167 patiënten met syndromale craniosynostose beschrijft, in de leeftijd van 1 tot 25 
jaar. De bevindingen van hoofdstuk 2 en 4 zijn samengevat in Tabel 1. De prevalentie 
van verhoogde hersendruk blijft hoog ook na schedelexpansie. Dit is voornamelijk te 
zien rond de leeftijd van 3 jaar. Aan de hand van deze gegevens wordt er een synd-
room specifieke richtlijn gepresenteerd.
Tabel 1 Resultaten hoofdstuk 2 en 4
Verhoogde 
hersendruk
OSA* Refractieve 
afwijkingen
Strabismus Gehoor 
verlies
Apert 33% 31% 76% 93% 44%
Crouzon/Pfeiffer 53% 27% 39% 63% 29%
Muenke 5% 5% 49% 39% 29%
Saethre-Chotzen 21% 5% 52% 37% 62%
* Prospectieve cijfers zijn hoger door afwezigheid van routinematige screening voor 
2006
De meeste craniofaciale chirurgen adviseren een eerste schedelexpansie voor het 
eerste levensjaar. Er zijn echter geen lange termijn resultaten aangaande de intel-
ligentie en de visus van dit behandelprotocol. In hoofdstuk 3 presenteren wij de 
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lange termijn resultaten van een studie in samenwerking met het craniofaciale 
centrum in Parijs. In deze studie hebben we 147 patiënten geincludeerd met Apert, 
Crouzon en Saethre-Chotzen die een vroege schedelexpansie hebben gehad en een 
IQ test op de leeftijd van 6 jaar of later. Hiernaast wordt van 39 patiënten uit Rotter-
dam de visus beschreven. Een goede lange termijn intelligentie werd geobserveerd 
in patiënten met Crouzon en Saethre-Chotzen. Patienten met het Apert syndroom 
hadden een significant lagere intelligentie vergeleken met de andere twee syndro-
men. In alle drie de syndroom groepen zitten significant meer patiënten met een IQ 
lager dan -2 standaard deviaties vergeleken met de normale populatie (46% Apert, 
16% Crouzon, 12% Saethre-Chotzen, 2.3% norm). In 8% van de patiënten was de vi-
sus 0.5 of lager gemeten met de Snellen kaart. Wij concluderen dat met het huidige 
beleid van vroege schedelexpansie een goede lange termijn intelligentie en visus be-
haald kan worden. Echter, ondanks een vroege schedelexpansie zullen er patiënten 
zijn met een laag IQ.
 Type, ernst en prevalentie van gehoorverlies per syndroom worden bes-
chreven in hoofdstuk 4. Patiënten met Apert, Crouzon en Saethre-Chotzen hebben 
met name een gehoorverlies met een geleidingscomponent. Terwijl patiënten met 
het Muenke 
syndroom met name een perceptief gehoorverlies hebben dat erger is in de lage 
frequenties. Dit gehoorverlies wordt alleen gezien bij patiënten met het Muenke 
syndroom. Aan de hand van deze bevindingen adviseren wij levenslange regel-
matige controle van het gehoor door de huisarts of KNO-arts, om te screenen op 
middenoorontstekingen met effusie. Verder adviseren wij te screenen op een per-
ceptief gehoorverlies bij kinderen met syndromale craniosynostose.
 Hoofdstuk 5 beschrijft de kwaliteit van leven gemeten met de Health Util-
ity Index mark 3 (HUI-3) en een Visual Analogue Scale (VAS). Alle patiënten werden 
vergeleken met Nederlandse normaal data. Visus, gehoor en intelligentie werden 
objectief gemeten en vergeleken met het corresponderende deel van de HUI-3. De 
HUI-3 en de VAS waren significant lager ten opzichte van de gemiddelde Nederland-
se populatie. Een groot deel van de ouders meldt dat hun kind problemen met de 
visus en/of spraak heeft. Een lagere intelligentie werd met name in patiënten met 
het Apert, Crouzon en Muenke syndroom gemeld. Moeite met lopen en handfunc-
tie werd met name gezien in Apert, Crouzon, Saethre-Chotzen en complexe cranio-
synostose. Alleen in patiënten met het Apert syndroom werd significant meer pijn 
gescoord. De HUI-3 onderdelen visus, gehoor en intelligentie hadden een gemiddeld 
tot sterke relatie met de objectief gemeten visus, gehoor en intelligentie.
 Aan de hand van verschillende vragenlijsten is de kwaliteit van leven en 
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beperkingen van de onderste en bovenste extremiteit bestudeerd in patiënten 
met het syndroom van Apert (hoofdstuk 6). De vragenlijsten werden beantwoord 
door de patiënt, de patiënt met behulp van een ouder/verzorger of alleen door een 
ouder verzorger. Ongeveer 60% van de patiënten met het syndroom van Apert heeft 
een beperking en kwaliteit van leven binnen de norm. De behaalde resultaten heb-
ben echter een brede spreiding en rond een derde deel van de patiënten heeft een 
zeer lage kwaliteit van leven en ernstige beperkingen. De ernst van de beperking 
van de extremiteiten was negatief gecorreleerd aan kwaliteit van leven. Ouders/ver-
zorgers scoorde gemiddeld lager op vragenlijsten over de beperking dan patiënten 
die de vragenlijst zelf beantwoorden. In de kwaliteit van leven vragenlijsten werd dit 
verschil niet gevonden.
 In hoofdstuk 7 presenteren we volume metingen van de hersenen en het 
ventrikel systeem. In de leeftijd van 1 tot 12 jaar is het hersenvolume gelijk aan dat 
van de norm populatie. De groei van de hersenen vindt met name plaats tijdens de 
eerste 5 jaar, waarna het stabiliseert. In de studiepopulatie werd een relatie gevon-
den tussen het volume van het ventrikelsysteem en het hebben van het Apert synd-
room of een Chiari I malformatie. Chiari I malformaties worden met name gezien in 
patiënten met het Crouzon syndroom. Daarom adviseren wij om in patiënten met 
het Apert en Crouzon syndroom te screenen op vergrote ventrikels en de aan-
wezigheid van Chiari I malformaties.
 Achterhoofdexpansies worden veelvuldig gebruikt als eerste schedelex-
pansie bij patiënten met Apert en Crouzon syndroom en craniofrontonasale dys-
plasie. Deze techniek geeft een grotere toename in volume en laat het aangezicht 
onaangeraakt wat bij een latere mono-block of facial bipartition de kans op com-
plicaties mogelijk verminderd. Het gebruik van metalen veren om het achterhoofd 
naar achter te duwen zou deze techniek nog verder kunnen verbeteren. In hoofd-
stuk 8 beschrijven we de achterhoofdexpansie met behulp van veren en vergelijken 
deze techniek met de conventionele techniek. Er zijn 31 kinderen geincludeerd 
waarvan er 15 met veren zijn behandeld en 16 met de conventionele techniek. 
Kinderen die met veren waren behandeld hadden een grotere toename van schede-
lomtrek en voorachterwaartse lengte van het hoofd. Bloedverlies en operatieduur 
waren niet significant verschillend. Er werden alleen milde complicaties gezien. Wij 
concluderen dat een schedelexpansie met veren geassocieerd is met een grotere 
toename van het intracraniële volume en een goed alternatief vormt voor de con-
ventionele techniek.
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